STOCK TITAN

Investview Q3 profit of $8.99M includes $9.59M gain

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Investview, Inc. (INVU) reported third-quarter 2026 net revenue of $2,238,580, down from $8,129,005 a year earlier; nine-month revenue was $8,054,983 versus $26,490,800. Operating losses were $2,061,924 for the quarter and $6,356,253 for nine months. Net income was $8,992,952, alongside a $9,588,570 gain on investment and a $1,717,496 unrealized gain on digital assets. Investview said it sold its private SPV investment for $12.8 million, recognizing a $9.6 million gain.

Nine-month operating cash outflow was $7,127,408, and cash and equivalents were $12,943,275 as of September 30, 2026. Management said available working capital and liquid assets supported operations for at least the next twelve months. The Polish Office of Competition and Consumer Protection issued a decision imposing a PLN 14,668,589 fine (approximately $4 million) and a cease-and-desist order; Investview appealed, enforcement is not final pending appeal, and approximately $3.81 million was accrued. Bitcoin mining operations were discontinued in July 2026.

1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 3 points

How the balance works

Positive

  • Moderate pointQuarterly net income reached $8,992,952, versus a net loss of $852,363 a year earlier.

Negative

  • Major pointPolish decision: PLN 14,668,589 fine; approximately $3.81 million accrued, appeal pending. 12% of market cap
  • Moderate pointNine-month revenue fell to $8,054,983 from $26,490,800 a year earlier.
  • Moderate pointNine-month operating cash outflow was $7,127,408, versus $3,105,886 in 2025.

Filing Explained

563,855,711 Class B units and 471,428,571 note-linked shares are potential, not completed, issuance; if issued, they would reduce existing holders’ percentage ownership.

This quarterly report discloses possible, rather than completed, share issuance through exchangeable units and convertible notes; if issued, those shares would reduce existing holders’ percentage ownership absent offsets.

Investview reports 563,855,711 Class B units that holders can exchange one-for-one for common shares, and 471,428,571 shares issuable upon conversion of notes.

Separately, 320,791,665 options to purchase common shares were outstanding at September 30, 2026, including 289,791,665 exercisable; none were exercised in the nine months ended September 30, 2026.

Third-quarter net revenue $2,238,580 Three months ended September 30, 2026; $8,129,005 for the same period in 2025.
Nine-month revenue $8,054,983 Nine months ended September 30, 2026; $26,490,800 for the same period in 2025.
Net income $8,992,952 Three months ended September 30, 2026; net loss of $852,363 for the same period in 2025.
Gain on investment $9,588,570 Three and nine months ended September 30, 2026.
Operating cash flow $7,127,408 used Net cash used in operating activities for the nine months ended September 30, 2026; $3,105,886 used in 2025.
Cash and cash equivalents $12,943,275 As of September 30, 2026.
Administrative fine PLN 14,668,589 (approximately $4 million) Polish Office of Competition and Consumer Protection decision; appeal pending.
Accrued loss contingency Approximately $3.81 million Accrued as of September 30, 2026 in connection with the Polish decision.
fair value financial
"measures digital assets at fair value"
Fair value is an estimate of what an asset or company is really worth today, derived from expected future earnings, comparable market prices and other relevant facts—like agreeing a price for a used car after checking mileage, condition and similar listings. Investors use fair value to decide whether a stock looks overpriced or undervalued, which helps guide buy, hold or sell decisions and sets expectations for potential returns and risk.
special purpose vehicle financial
"invested an aggregate of $3.25 million in a special purpose vehicle"
A special purpose vehicle (SPV) is a separate legal entity created to isolate financial risk or hold specific assets, much like a dedicated safe for a particular investment or project. Investors pay attention to SPVs because they can influence how risks and rewards are managed, and sometimes they are used to structure transactions more efficiently or hide certain financial details.
working capital financial
"working capital of $9.6 million"
Working capital is the money a business has available to cover its daily expenses, like paying bills and buying supplies. It’s like the cash in your wallet that helps you handle everyday costs; having enough ensures the business can operate smoothly without running into money shortages.
anti-dilutive financial
"their inclusion would be anti-dilutive"
A claim, security feature, or action described as anti-dilutive prevents or does not cause a reduction in existing shareholders’ per-share values when additional shares could be issued. For example, certain convertible securities or corporate actions are treated as anti-dilutive for earnings-per-share calculations if including them would raise EPS rather than lower it; investors watch this because it affects reported per-share metrics, ownership percentages, and valuation comparisons, like keeping pie slices the same size instead of making them smaller.
discontinued operations financial
"disclosed our discontinued operations separately"
Discontinued operations are parts of a company that it has decided to sell or shut down, and no longer plans to run in the future. This matters to investors because it helps them understand which parts of the business are ongoing and which are being phased out, providing a clearer picture of the company’s current performance and future prospects. Think of it like a store closing a department—it no longer contributes to sales or profits.
cease and desist regulatory
"the fine and cease and desist components"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much revenue did INVU report in Q3 2026?

INVU reported net revenue of $2,238,580 for the three months ended September 30, 2026, compared with $8,129,005 for the same period in 2025. For the nine months ended September 30, 2026, revenue was $8,054,983, compared with $26,490,800 a year earlier.

Why did INVU report Q3 2026 net income despite an operating loss?

Investview reported net income of $8,992,952 and an operating loss of $2,061,924 for the quarter. Other income included a $9,588,570 gain on investment and a $1,717,496 unrealized gain on digital assets. Net income for the same quarter in 2025 was a loss of $852,363.

What was the Polish regulator's fine against INVU, and is the appeal pending?

The Polish Office of Competition and Consumer Protection's December 2025 decision imposed a PLN 14,668,589 administrative fine (approximately $4 million) and a cease-and-desist order. Investview appealed in February 2026; the appeal is pending, and enforcement is not final during the appeal.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false --12-31 Q3 0000862651 0000862651 2026-01-01 2026-09-30 0000862651 2026-11-06 0000862651 2026-09-30 0000862651 2025-12-31 0000862651 us-gaap:RelatedPartyMember 2026-09-30 0000862651 us-gaap:RelatedPartyMember 2025-12-31 0000862651 us-gaap:NonrelatedPartyMember 2026-09-30 0000862651 us-gaap:NonrelatedPartyMember 2025-12-31 0000862651 2026-07-01 2026-09-30 0000862651 2025-07-01 2025-09-30 0000862651 2025-01-01 2025-09-30 0000862651 INVU:MembershipRevenueMember 2026-07-01 2026-09-30 0000862651 INVU:MembershipRevenueMember 2025-07-01 2025-09-30 0000862651 INVU:MembershipRevenueMember 2026-01-01 2026-09-30 0000862651 INVU:MembershipRevenueMember 2025-01-01 2025-09-30 0000862651 INVU:HealthAndWellnessRevenueMember 2026-07-01 2026-09-30 0000862651 INVU:HealthAndWellnessRevenueMember 2025-07-01 2025-09-30 0000862651 INVU:HealthAndWellnessRevenueMember 2026-01-01 2026-09-30 0000862651 INVU:HealthAndWellnessRevenueMember 2025-01-01 2025-09-30 0000862651 INVU:CoffeeSalesMember 2026-07-01 2026-09-30 0000862651 INVU:CoffeeSalesMember 2025-07-01 2025-09-30 0000862651 INVU:CoffeeSalesMember 2026-01-01 2026-09-30 0000862651 INVU:CoffeeSalesMember 2025-01-01 2025-09-30 0000862651 INVU:OtherMember 2026-07-01 2026-09-30 0000862651 INVU:OtherMember 2025-07-01 2025-09-30 0000862651 INVU:OtherMember 2026-01-01 2026-09-30 0000862651 INVU:OtherMember 2025-01-01 2025-09-30 0000862651 us-gaap:PreferredStockMember 2024-12-31 0000862651 us-gaap:CommonStockMember 2024-12-31 0000862651 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000862651 us-gaap:TreasuryStockCommonMember 2024-12-31 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0000862651 us-gaap:RetainedEarningsMember 2024-12-31 0000862651 us-gaap:NoncontrollingInterestMember 2024-12-31 0000862651 2024-12-31 0000862651 us-gaap:PreferredStockMember 2025-03-31 0000862651 us-gaap:CommonStockMember 2025-03-31 0000862651 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0000862651 us-gaap:TreasuryStockCommonMember 2025-03-31 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0000862651 us-gaap:RetainedEarningsMember 2025-03-31 0000862651 us-gaap:NoncontrollingInterestMember 2025-03-31 0000862651 2025-03-31 0000862651 us-gaap:PreferredStockMember 2025-06-30 0000862651 us-gaap:CommonStockMember 2025-06-30 0000862651 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0000862651 us-gaap:TreasuryStockCommonMember 2025-06-30 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0000862651 us-gaap:RetainedEarningsMember 2025-06-30 0000862651 us-gaap:NoncontrollingInterestMember 2025-06-30 0000862651 2025-06-30 0000862651 us-gaap:PreferredStockMember 2025-12-31 0000862651 us-gaap:CommonStockMember 2025-12-31 0000862651 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0000862651 us-gaap:TreasuryStockCommonMember 2025-12-31 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0000862651 us-gaap:RetainedEarningsMember 2025-12-31 0000862651 us-gaap:NoncontrollingInterestMember 2025-12-31 0000862651 us-gaap:PreferredStockMember 2026-03-31 0000862651 us-gaap:CommonStockMember 2026-03-31 0000862651 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0000862651 us-gaap:TreasuryStockCommonMember 2026-03-31 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0000862651 us-gaap:RetainedEarningsMember 2026-03-31 0000862651 us-gaap:NoncontrollingInterestMember 2026-03-31 0000862651 2026-03-31 0000862651 us-gaap:PreferredStockMember 2026-06-30 0000862651 us-gaap:CommonStockMember 2026-06-30 0000862651 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0000862651 us-gaap:TreasuryStockCommonMember 2026-06-30 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-06-30 0000862651 us-gaap:RetainedEarningsMember 2026-06-30 0000862651 us-gaap:NoncontrollingInterestMember 2026-06-30 0000862651 2026-06-30 0000862651 us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0000862651 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0000862651 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0000862651 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-31 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0000862651 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0000862651 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0000862651 2025-01-01 2025-03-31 0000862651 us-gaap:PreferredStockMember 2025-04-01 2025-06-30 0000862651 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0000862651 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0000862651 us-gaap:TreasuryStockCommonMember 2025-04-01 2025-06-30 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-04-01 2025-06-30 0000862651 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0000862651 us-gaap:NoncontrollingInterestMember 2025-04-01 2025-06-30 0000862651 2025-04-01 2025-06-30 0000862651 us-gaap:PreferredStockMember 2025-07-01 2025-09-30 0000862651 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0000862651 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0000862651 us-gaap:TreasuryStockCommonMember 2025-07-01 2025-09-30 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-07-01 2025-09-30 0000862651 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0000862651 us-gaap:NoncontrollingInterestMember 2025-07-01 2025-09-30 0000862651 us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0000862651 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0000862651 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0000862651 us-gaap:TreasuryStockCommonMember 2026-01-01 2026-03-31 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-03-31 0000862651 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0000862651 us-gaap:NoncontrollingInterestMember 2026-01-01 2026-03-31 0000862651 2026-01-01 2026-03-31 0000862651 us-gaap:PreferredStockMember 2026-04-01 2026-06-30 0000862651 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0000862651 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0000862651 us-gaap:TreasuryStockCommonMember 2026-04-01 2026-06-30 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-04-01 2026-06-30 0000862651 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0000862651 us-gaap:NoncontrollingInterestMember 2026-04-01 2026-06-30 0000862651 2026-04-01 2026-06-30 0000862651 us-gaap:PreferredStockMember 2026-07-01 2026-09-30 0000862651 us-gaap:CommonStockMember 2026-07-01 2026-09-30 0000862651 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0000862651 us-gaap:TreasuryStockCommonMember 2026-07-01 2026-09-30 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-07-01 2026-09-30 0000862651 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0000862651 us-gaap:NoncontrollingInterestMember 2026-07-01 2026-09-30 0000862651 us-gaap:PreferredStockMember 2025-09-30 0000862651 us-gaap:CommonStockMember 2025-09-30 0000862651 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0000862651 us-gaap:TreasuryStockCommonMember 2025-09-30 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-09-30 0000862651 us-gaap:RetainedEarningsMember 2025-09-30 0000862651 us-gaap:NoncontrollingInterestMember 2025-09-30 0000862651 2025-09-30 0000862651 us-gaap:PreferredStockMember 2026-09-30 0000862651 us-gaap:CommonStockMember 2026-09-30 0000862651 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0000862651 us-gaap:TreasuryStockCommonMember 2026-09-30 0000862651 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-09-30 0000862651 us-gaap:RetainedEarningsMember 2026-09-30 0000862651 us-gaap:NoncontrollingInterestMember 2026-09-30 0000862651 INVU:ContributionAgreementMember INVU:WealthGeneratorsLLCMember 2017-04-01 0000862651 INVU:ContributionAgreementMember INVU:WealthGeneratorsLLCMember 2017-04-01 2017-04-01 0000862651 INVU:AcquisitionAgreementMember INVU:MarketTrendStrategiesLLCMember 2017-06-06 2017-06-06 0000862651 INVU:ElRTTechnologiesLLCMember 2026-09-30 0000862651 INVU:RenuLaboratoriesIncMember 2024-10-11 0000862651 INVU:MembershipRevenueMember 2026-09-30 0000862651 INVU:MembershipRevenueMember 2025-12-31 0000862651 INVU:CoffeeSalesMember 2026-09-30 0000862651 INVU:ForeignRevenueMember 2026-07-01 2026-09-30 0000862651 INVU:DomesticRevenueMember 2026-07-01 2026-09-30 0000862651 INVU:ForeignRevenueMember 2025-07-01 2025-09-30 0000862651 INVU:DomesticRevenueMember 2025-07-01 2025-09-30 0000862651 INVU:ForeignRevenueMember 2026-01-01 2026-09-30 0000862651 INVU:DomesticRevenueMember 2026-01-01 2026-09-30 0000862651 INVU:ForeignRevenueMember 2025-01-01 2025-09-30 0000862651 INVU:DomesticRevenueMember 2025-01-01 2025-09-30 0000862651 us-gaap:FurnitureAndFixturesMember 2026-09-30 0000862651 us-gaap:FurnitureAndFixturesMember 2025-12-31 0000862651 us-gaap:ComputerEquipmentMember 2026-09-30 0000862651 us-gaap:ComputerEquipmentMember 2025-12-31 0000862651 INVU:ManufacturingEquipmentMember 2026-09-30 0000862651 INVU:ManufacturingEquipmentMember 2025-12-31 0000862651 INVU:ManufacturingEquipmentMember srt:MinimumMember 2026-09-30 0000862651 INVU:ManufacturingEquipmentMember srt:MaximumMember 2026-09-30 0000862651 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2026-09-30 0000862651 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2026-09-30 0000862651 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2026-09-30 0000862651 us-gaap:FairValueMeasurementsRecurringMember 2026-09-30 0000862651 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0000862651 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0000862651 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0000862651 us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0000862651 INVU:OtherRevenueMember 2026-07-01 2026-09-30 0000862651 INVU:OtherRevenueMember 2025-07-01 2025-09-30 0000862651 INVU:OtherRevenueMember 2026-01-01 2026-09-30 0000862651 INVU:OtherRevenueMember 2025-01-01 2025-09-30 0000862651 us-gaap:EmployeeStockOptionMember 2025-07-01 2025-09-30 0000862651 us-gaap:WarrantMember 2025-07-01 2025-09-30 0000862651 us-gaap:ConvertibleDebtSecuritiesMember 2025-07-01 2025-09-30 0000862651 INVU:ConversionOfNonVotingMembershipInterestMember 2025-07-01 2025-09-30 0000862651 us-gaap:EmployeeStockOptionMember us-gaap:SegmentContinuingOperationsMember 2026-07-01 2026-09-30 0000862651 us-gaap:EmployeeStockOptionMember us-gaap:SegmentDiscontinuedOperationsMember 2026-07-01 2026-09-30 0000862651 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-09-30 0000862651 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-09-30 0000862651 us-gaap:WarrantMember 2026-01-01 2026-09-30 0000862651 us-gaap:WarrantMember 2025-01-01 2025-09-30 0000862651 us-gaap:ConvertibleDebtSecuritiesMember 2026-01-01 2026-09-30 0000862651 us-gaap:ConvertibleDebtSecuritiesMember 2025-01-01 2025-09-30 0000862651 INVU:ConversionOfNonVotingMembershipInterestMember 2026-01-01 2026-09-30 0000862651 INVU:ConversionOfNonVotingMembershipInterestMember 2025-01-01 2025-09-30 0000862651 us-gaap:EmployeeStockOptionMember us-gaap:SegmentContinuingOperationsMember 2026-01-01 2026-09-30 0000862651 us-gaap:EmployeeStockOptionMember us-gaap:SegmentContinuingOperationsMember 2025-01-01 2025-09-30 0000862651 us-gaap:WarrantMember us-gaap:SegmentContinuingOperationsMember 2026-01-01 2026-09-30 0000862651 us-gaap:WarrantMember us-gaap:SegmentContinuingOperationsMember 2025-01-01 2025-09-30 0000862651 INVU:DreamVenturesLLCMember 2026-09-30 0000862651 2025-01-01 2025-01-01 0000862651 us-gaap:RetainedEarningsMember 2025-01-01 2025-01-01 0000862651 INVU:BitcoinMember 2026-09-30 0000862651 INVU:USDCMember 2026-09-30 0000862651 INVU:USDTMember 2026-09-30 0000862651 INVU:ConvertiblePromissoryNoteOneMember 2026-09-30 0000862651 INVU:ConvertiblePromissoryNoteOneMember 2025-12-31 0000862651 INVU:ConvertiblePromissoryNoteTwoMember 2026-09-30 0000862651 INVU:ConvertiblePromissoryNoteTwoMember 2025-12-31 0000862651 INVU:ConvertiblePromissoryNoteThreeMember 2026-09-30 0000862651 INVU:ConvertiblePromissoryNoteThreeMember 2025-12-31 0000862651 INVU:WorkingCapitalPromissoryNoteMember 2026-09-30 0000862651 INVU:WorkingCapitalPromissoryNoteMember 2025-12-31 0000862651 INVU:ConvertiblePromissoryNoteOneMember 2026-09-30 0000862651 INVU:ConvertiblePromissoryNoteTwoMember 2026-09-30 0000862651 INVU:ConvertiblePromissoryNoteThreeMember 2026-09-30 0000862651 INVU:DBRCapitalLLCMember INVU:ConvertiblePromissoryNoteOneMember 2020-04-27 2020-04-27 0000862651 INVU:DBRCapitalLLCMember INVU:ConvertiblePromissoryNoteOneMember 2020-04-27 0000862651 INVU:DBRCapitalLLCMember INVU:ConvertiblePromissoryNoteOneMember 2020-11-09 0000862651 INVU:DBRCapitalLLCMember INVU:ConvertiblePromissoryNoteOneMember 2026-01-01 2026-09-30 0000862651 INVU:DBRCapitalLLCMember INVU:ConvertiblePromissoryNoteTwoMember 2020-05-27 2020-05-27 0000862651 INVU:DBRCapitalLLCMember INVU:ConvertiblePromissoryNoteTwoMember 2020-05-27 0000862651 INVU:DBRCapitalLLCMember INVU:ConvertiblePromissoryNoteTwoMember 2026-01-01 2026-09-30 0000862651 INVU:ConvertiblePromissoryNoteThreeMember INVU:DBRCapitalLLCMember 2020-11-09 2020-11-09 0000862651 INVU:ConvertiblePromissoryNoteThreeMember INVU:DBRCapitalLLCMember 2020-11-09 0000862651 INVU:ConvertiblePromissoryNoteThreeMember INVU:DBRCapitalLLCMember 2026-01-01 2026-09-30 0000862651 INVU:SecuritiesPurchaseAgreementsMember INVU:SSATechnologiesLLCMember 2021-03-22 0000862651 INVU:SecuritiesPurchaseAgreementsMember INVU:SSATechnologiesLLCMember INVU:WorkingCapitalPromissoryNoteMember srt:MaximumMember 2021-03-22 0000862651 INVU:SecuritiesPurchaseAgreementsMember INVU:SSATechnologiesLLCMember INVU:WorkingCapitalPromissoryNoteMember 2026-09-30 0000862651 INVU:SecuritiesPurchaseAgreementsMember INVU:SSATechnologiesLLCMember INVU:WorkingCapitalPromissoryNoteMember 2021-03-22 0000862651 INVU:SecuritiesPurchaseAgreementsMember INVU:SSATechnologiesLLCMember INVU:WorkingCapitalPromissoryNoteMember 2026-01-01 2026-09-30 0000862651 INVU:SecuritiesPurchaseAgreementsMember INVU:SSATechnologiesLLCMember INVU:WorkingCapitalPromissoryNoteMember 2021-03-22 2021-03-22 0000862651 INVU:DBRCapitalLLCMember INVU:SecuritiesPurchaseAgreementsMember 2020-04-27 2020-04-27 0000862651 INVU:StockPurchaseAndReleaseAgreementMember INVU:MarioRomanoAndAnnetteRaynorMember 2023-09-29 2023-09-29 0000862651 INVU:StockPurchaseAndReleaseAgreementMember INVU:RyanSmithAndChandMillerMember 2023-09-29 0000862651 us-gaap:CommonStockMember INVU:StockPurchaseAndReleaseAgreementMember INVU:RyanSmithAndChandMillerMember 2024-02-07 2024-02-07 0000862651 us-gaap:CommonStockMember INVU:StockPurchaseAndReleaseAgreementMember INVU:RyanSmithAndChandMillerMember 2024-02-07 0000862651 INVU:StockPurchaseAndReleaseAgreementMember INVU:RyanSmithAndChandMillerMember 2025-01-01 2025-09-30 0000862651 INVU:USSmallBusinessAdministrationMember 2026-09-30 0000862651 INVU:USSmallBusinessAdministrationMember 2025-12-31 0000862651 INVU:InsurancePolicyLoanMember 2026-09-30 0000862651 INVU:InsurancePolicyLoanMember 2025-12-31 0000862651 INVU:USSmallBusinessAdministrationMember 2020-04-01 2020-04-30 0000862651 INVU:USSmallBusinessAdministrationMember 2020-04-30 0000862651 INVU:USSmallBusinessAdministrationMember 2026-01-01 2026-09-30 0000862651 INVU:InsurancePremiumsMember 2026-08-01 2026-08-31 0000862651 INVU:InsurancePremiumsMember 2026-08-31 0000862651 INVU:InsurancePremiumsMember 2026-01-01 2026-09-30 0000862651 INVU:WyckoffLeaseMember 2021-07-01 2021-07-31 0000862651 INVU:WyckoffLeaseMember 2021-07-31 0000862651 INVU:WyckoffLeaseMember INVU:FirstExtensionMember 2026-01-01 2026-09-30 0000862651 INVU:WyckoffLeaseMember INVU:SecondExtensionMember 2026-01-01 2026-09-30 0000862651 INVU:HaverfordLeaseMember 2021-09-30 0000862651 INVU:HaverfordLeaseMember 2026-01-01 2026-09-30 0000862651 INVU:WarminsterLeaseMember 2024-11-01 2024-11-30 0000862651 INVU:IvylandLeaseMember 2024-12-01 2024-12-31 0000862651 us-gaap:SeriesBPreferredStockMember 2026-09-30 0000862651 us-gaap:SeriesBPreferredStockMember 2026-01-01 2026-09-30 0000862651 us-gaap:SeriesBPreferredStockMember 2025-01-01 2025-09-30 0000862651 INVU:StockRepurchaseProgramMember us-gaap:CommonStockMember 2025-03-06 0000862651 INVU:StockRepurchaseProgramMember us-gaap:CommonStockMember 2026-01-01 2026-09-30 0000862651 INVU:StockRepurchaseProgramMember us-gaap:CommonStockMember 2025-01-01 2025-09-30 0000862651 INVU:IncentivePlanTwoThousandTwentyTwoMember 2026-09-30 0000862651 INVU:IncentivePlanTwoThousandTwentyTwoMember INVU:RobertVerdunMember 2026-01-01 2026-09-30 0000862651 INVU:IncentivePlanTwoThousandTwentyTwoMember INVU:RobertVerdunMember 2026-09-30 0000862651 us-gaap:CommonStockMember srt:ManagementMember 2026-06-01 2026-06-30 0000862651 us-gaap:CommonStockMember INVU:TerminationOfEmployeesMember 2026-01-01 2026-09-30 0000862651 INVU:InvestviewFinancialGroupHoldingLLCMember INVU:ClassBUnitsMember 2026-09-30 0000862651 INVU:InvestviewFinancialGroupHoldingLLCMember INVU:ClassBUnitsMember 2025-12-31 0000862651 INVU:InvestviewFinancialGroupHoldingLLCMember INVU:ClassBUnitsMember 2026-01-01 2026-09-30 0000862651 us-gaap:CommonStockMember 2025-01-01 2025-12-31 0000862651 INVU:InvestviewFinancialGroupHoldingsLlcClassBUnitsMember 2025-01-01 2025-12-31 0000862651 2025-01-17 2025-01-17 0000862651 INVU:PromissoryNoteMember 2020-06-01 2020-06-30 0000862651 INVU:PromissoryNoteMember 2024-12-01 2024-12-31 0000862651 2023-08-01 2023-08-31 0000862651 2021-10-01 2021-12-31 0000862651 INVU:FinesAndPenaltiesMember 2025-12-01 2025-12-31 0000862651 INVU:JosephCammarataMember 2021-03-30 0000862651 INVU:JosephCammarataMember 2021-09-21 0000862651 INVU:JosephCammarataMember 2022-03-01 2022-03-31 0000862651 INVU:WorkingCapitalPromissoryNoteMember INVU:SSATechnologiesLLCMember INVU:SecuritiesPurchaseAgreementsMember srt:MaximumMember 2021-03-22 0000862651 INVU:WorkingCapitalPromissoryNoteMember INVU:SSATechnologiesLLCMember INVU:SecuritiesPurchaseAgreementsMember 2021-03-22 0000862651 INVU:WorkingCapitalPromissoryNoteMember INVU:SSATechnologiesLLCMember INVU:SecuritiesPurchaseAgreementsMember 2026-09-30 0000862651 INVU:WorkingCapitalPromissoryNoteMember INVU:SSATechnologiesLLCMember INVU:SecuritiesPurchaseAgreementsMember 2026-01-01 2026-09-30 0000862651 INVU:WorkingCapitalPromissoryNoteMember INVU:SSATechnologiesLLCMember INVU:SecuritiesPurchaseAgreementsMember 2025-03-22 2025-03-22 0000862651 us-gaap:ReportableSubsegmentsMember INVU:DirectToConsumerMarketingPlatformMember 2026-07-01 2026-09-30 0000862651 us-gaap:ReportableSubsegmentsMember INVU:ManufacturingAndDevelopmentOfHealthBeautyAndWellnessProductsMember 2026-07-01 2026-09-30 0000862651 us-gaap:ReportableSubsegmentsMember 2026-07-01 2026-09-30 0000862651 us-gaap:ReportableSubsegmentsMember INVU:DirectToConsumerMarketingPlatformMember 2025-07-01 2025-09-30 0000862651 us-gaap:ReportableSubsegmentsMember INVU:ManufacturingAndDevelopmentOfHealthBeautyAndWellnessProductsMember 2025-07-01 2025-09-30 0000862651 us-gaap:ReportableSubsegmentsMember 2025-07-01 2025-09-30 0000862651 us-gaap:ReportableSubsegmentsMember INVU:DirectToConsumerMarketingPlatformMember 2026-01-01 2026-09-30 0000862651 us-gaap:ReportableSubsegmentsMember INVU:ManufacturingAndDevelopmentOfHealthBeautyAndWellnessProductsMember 2026-01-01 2026-09-30 0000862651 us-gaap:ReportableSubsegmentsMember 2026-01-01 2026-09-30 0000862651 us-gaap:ReportableSubsegmentsMember INVU:DirectToConsumerMarketingPlatformMember 2025-01-01 2025-09-30 0000862651 us-gaap:ReportableSubsegmentsMember INVU:ManufacturingAndDevelopmentOfHealthBeautyAndWellnessProductsMember 2025-01-01 2025-09-30 0000862651 us-gaap:ReportableSubsegmentsMember 2025-01-01 2025-09-30 0000862651 INVU:SafetEkLLCMember 2026-09-30 0000862651 INVU:SafetEkLLCMember 2025-12-31 0000862651 INVU:SafetEkLLCMember INVU:MiningRevenueMember 2026-07-01 2026-09-30 0000862651 INVU:SafetEkLLCMember INVU:MiningRevenueMember 2025-07-01 2025-09-30 0000862651 INVU:SafetEkLLCMember INVU:MiningRevenueMember 2026-01-01 2026-09-30 0000862651 INVU:SafetEkLLCMember INVU:MiningRevenueMember 2025-01-01 2025-09-30 0000862651 INVU:SafetEkLLCMember 2026-07-01 2026-09-30 0000862651 INVU:SafetEkLLCMember 2025-07-01 2025-09-30 0000862651 INVU:SafetEkLLCMember 2026-01-01 2026-09-30 0000862651 INVU:SafetEkLLCMember 2025-01-01 2025-09-30 0000862651 INVU:DataProcessingEquipmentMember 2026-09-30 0000862651 INVU:StockRepurchaseProgramMember us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2026-10-01 2026-10-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure INVU:Segment iso4217:PLN

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED

 

September 30, 2026

 

or

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from__________________ to _______________________.

 

Commission File Number 000-27019

 

Investview, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada   87-0369205

(State or other jurisdiction

of incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

521 West Lancaster Avenue, Second Floor,

Haverford, Pennsylvania

  19041
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: 732-889-4300

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
         

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

 

Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
Emerging growth company ☐  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

Yes ☐ No ☒

 

As of November 6, 2026, there were 1,842,419,385 shares of common stock, $0.001 par value, outstanding.

 

 

 

 

 

 

INVESTVIEW, INC.

 

Form 10-Q for the Three and Nine Months Ended September 30, 2026

 

Table of Contents

 

PART I – FINANCIAL INFORMATION   3
ITEM 1 – FINANCIAL STATEMENTS   3
Condensed Consolidated Balance Sheets as of September 30, 2026 (Unaudited) and December 31, 2025   3
Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) for the Three and Nine Months Ended September 30, 2026 and 2025 (Unaudited)   4
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) for the Three and Nine Months Ended September 30, 2026 and 2025 (Unaudited)   5
Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2026 and 2025 (Unaudited)   6
Notes to Condensed Consolidated Financial Statements as of September 30, 2026 (Unaudited)   7
ITEM 2 – MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS   34
ITEM 3 – QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK   42
ITEM 4 – CONTROLS AND PROCEDURES   42
PART II – OTHER INFORMATION   43
ITEM 1 – LEGAL PROCEEDINGS   43
ITEM 1.A – RISK FACTORS   43
ITEM 2 – UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS   43
ITEM 3 – DEFAULTS UPON SENIOR SECURITIES   43
ITEM 4 – MINE SAFETY DISCLOSURES   43
ITEM 5 – OTHER INFORMATION   43
ITEM 6 – EXHIBITS   44
SIGNATURE PAGE   45

 

2

 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1 – FINANCIAL STATEMENTS

 

INVESTVIEW, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   September 30,   December 31, 
   2026   2025 
         
ASSETS          
Current assets:          
Cash and cash equivalents  $12,943,275   $9,992,443 
Prepaid assets   400,258    361,444 
Deposits, current   109,708    104,926 
Receivables   230,471    556,384 
Inventory   844,969    663,000 
Income tax paid in advance   261,429    367,718 
Current assets of discontinued operations   40,395    949,628 
Total current assets   14,830,505    12,995,543 
           
Fixed assets, net   1,507,852    1,524,730 
Fixed assets, net of discontinued operations   -    118,257 
Total fixed assets, net   1,507,852    1,642,987 
           
Other assets:          
Digital assets   5,664,813    5,464,011 
Equity investment   -    1,250,000 
Intangible assets, net   10,799    10,799 
Operating lease right-of-use asset   11,356    76,774 
Deposits   13,699    19,421 
Other assets of discontinued operations   -    37,320 
Total other assets   5,700,667    6,858,325 
           
Total assets  $22,039,024   $21,496,855 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)          
Current liabilities:          
Accounts payable and accrued liabilities  $2,992,797   $3,325,346 
Payroll liabilities   171,739    55,983 
Income tax payable   106,408    215,752 
Deferred revenue   406,794    952,977 
Dividend liability   231,893    239,776 
Operating lease liability, current   11,575    70,344 
Related party debt, net of discounts, current   1,206,877    1,205,887 
Debt, net of discounts, current   101,855    29,244 
Current liabilities of discontinued operations   3,649    15,854 
Total current liabilities    5,233,587    6,111,163 
           
Operating lease liability, long term   -    6,539 
Accrued liabilities, long term   3,864,023    4,135,276 
Related party debt, net of discounts, long term   2,091,440    1,838,808 
Debt, net of discounts, long term   472,246    480,155 
Total long-term liabilities   6,427,709    6,460,778 
           
Total liabilities   11,661,296    12,571,941 
           
Commitments and contingencies   -    - 
           
Stockholders’ equity (deficit):          
Preferred stock, par value: $0.001; 50,000,000 shares authorized, 252,192 and 252,192 issued and outstanding as of September 30, 2026 and December 31, 2025, respectively   252    252 
Common stock, par value $0.001; 10,000,000,000 shares authorized; 1,860,376,075 and 1,860,376,075 shares issued and 1,843,064,482 and 1,847,886,365 outstanding as of September 30, 2026 and December 31, 2025, respectively   1,860,375    1,860,375 
Additional paid in capital   104,394,465    104,110,876 
Treasury stock, at cost, 17,311,593 and 12,489,710 shares as of September 30, 2026 and December 31, 2025, respectively   (352,611)   (246,898)
Accumulated other comprehensive income (loss)   (23,218)   (23,218)
Accumulated deficit   (95,516,338)   (96,789,073)
Accumulated noncontrolling interest   14,803    12,600 
Total stockholders’ equity (deficit)   10,377,728    8,924,914 
           
Total liabilities and stockholders’ equity (deficit)  $22,039,024   $21,496,855 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3

 

 

INVESTVIEW, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

AND OTHER COMPREHENSIVE INCOME (LOSS)

 

   2026   2025   2026   2025 
   Three months ended September 30,   Nine months ended September 30, 
   2026   2025   2026   2025 
                 
Revenue:                    
Membership revenue, net of refunds, incentives, credits, and chargebacks  $1,819,488   $7,066,734   $6,659,883   $23,702,859 
Health and wellness product sales   238,372    1,029,673    749,696    2,709,692 
Coffee sales   177,636    -    630,141    - 
Other revenue   3,084    32,598    15,263    78,249 
Total revenue, net   2,238,580    8,129,005    8,054,983    26,490,800 
                     
Operating costs and expenses:                    
Cost of sales and service   336,811    1,101,304    1,148,580    3,017,091 
Commissions   1,229,147    4,008,062    4,226,135    13,260,667 
Salary and related   1,380,535    1,717,067    4,317,405    4,930,547 
Professional fees   286,646    534,687    1,426,959    1,538,395 
General and administrative   1,067,365    1,454,817    3,292,157    3,782,408 
Total operating costs and expenses   4,300,504    8,815,937    14,411,236    26,529,108 
                     
Net income (loss) from operations   (2,061,924)   (686,932)   (6,356,253)   (38,308)
                     
Other income (expense):                    
Gain (loss) on settlement   -    (111,277)   -    (111,277)
Gain (loss) on investment   9,588,570    -    9,588,570    - 
Gain (loss) on fair value of derivative liability   -    (20)   -    133 
Realized gain (loss) on digital assets   (37,997)   (42,737)   (89,728)   77,006 
Unrealized gain (loss) on digital assets   1,717,496    219,771    19,100    399,029 
Interest expense   (5,620)   (4,726)   (14,918)   (16,682)
Interest expense, related parties   (310,594)   (310,594)   (929,008)   (929,008)
Other income (expense)   148,367    371,782    445,200    758,108 
Total other income (expense)   11,100,222    122,199    9,019,216    177,309 
                     
Income (loss) from continued operations before income taxes   9,038,298    (564,733)   2,662,963    139,001 
Income tax benefit (expense)   (160,104)   -    (162,657)   (11,000)
Net income (loss) of continued operations   8,878,194    (564,733)   2,500,306    128,001 
                     
Discontinued operations:                    
Net income (loss) of discontinued operations before income taxes   13,432    (287,630)   (712,189)   (1,239,939)
Income tax benefit (expense)   101,326    -    101,326    - 
Net income (loss) of discontinued operations   114,758    (287,630)   (610,863)   (1,239,939)
                     
Net income (loss)   8,992,952    (852,363)   1,889,443    (1,111,938)
Net income (loss) attributable to noncontrolling interest   (147)   1,780    2,203    2,574 
Net income (loss) attributable to Investview, Inc.   8,993,099    (854,143)   1,887,240    (1,114,512)
                     
Dividends on Preferred Stock   (204,835)   (204,835)   (614,505)   (614,505)
                     
Net income (loss) applicable to common shareholders  $8,788,264   $(1,058,978)  $1,272,735   $(1,729,017)
                     
Continuing operations:                    
Basic income (loss) per common share  $0.00   $(0.00)  $0.00   $0.00 
Diluted income (loss) per common share  $0.00   $(0.00)  $0.00   $0.00 
                     
Basic weighted average number of common shares outstanding   1,844,159,552    1,853,465,349    1,845,558,194    1,856,658,888 
Diluted weighted average number of common shares outstanding   2,879,443,834    1,853,465,349    2,880,842,476    2,893,087,459 
                     
Discontinuing operations:                    
Basic income (loss) per common share  $0.00   $(0.00)  $(0.00)  $(0.00)
Diluted income (loss) per common share  $0.00   $(0.00)  $(0.00)  $(0.00)
                     
Basic weighted average number of common shares outstanding   1,844,159,552    1,853,465,349    1,845,558,194    1,856,658,888 
Diluted weighted average number of common shares outstanding   2,879,443,834    1,853,465,349    1,845,558,194    1,856,658,888 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4

 

 

INVESTVIEW, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025

 

                               Accumulated             
                   Additional           Other             
   Preferred Stock   Common Stock   Paid in   Treasury Stock   Comprehensive   Accumulated   Noncontrolling     
   Shares   Amount   Shares   Amount   Capital   Shares   Amount   Income (Loss)   Deficit   Interest   Total 
Balance, December 31, 2024   252,192   $252    1,859,231,786   $1,859,231   $102,560,320    -   $-   $(23,218)  $(87,205,070)  $8,070   $17,199,585 
Cumulative effect adjustment upon adoption of ASU 2023-08   -    -    -    -    -    -    -    -    148,346    -    148,346 
Common stock issued for services and other stock-based compensation   -    -    -    -    387,634    -    -    -    -    -    387,634 
Common stock repurchased and held as treasury stock   -    -    -    -    -    1,089,286    (24,006)   -    -    -    (24,006)
Dividends   -    -    -    -    -    -    -    -    (204,835)   -    (204,835)
Net income (loss)   -    -    -    -    -    -    -    -    (685,866)   (1,987)   (687,853)
Balance, March 31, 2025   252,192   $252    1,859,231,786   $1,859,231   $102,947,954    1,089,286   $(24,006)  $(23,218)  $(87,947,425)  $6,083   $16,818,871 
Common stock issued for services and other stock-based compensation   -    -    -    -    386,238    -    -    -    -    -    386,238 
Common stock repurchased and held as treasury stock   -    -    -    -    -    1,870,931    (20,636)   -    -    -    (20,636)
Dividends   -    -    -    -    -    -    -    -    (204,835)   -    (204,835)
Net income (loss)   -    -    -    -    -    -    -    -    425,497    2,781    428,278 
Balance, June 30, 2025   252,192   $252    1,859,231,786   $1,859,231   $103,334,192    2,960,217   $(44,642)  $(23,218)  $(87,726,763)  $8,864   $17,407,916 
Common stock issued for services and other stock-based compensation   -    -    -    -    390,483    -    -    -    -    -    390,483 
Common stock repurchased and held as treasury stock   -    -    -    -    -    5,541,286    (92,619)   -    -    -    (92,619)
Dividends   -    -    -    -    -    -    -    -    (204,835)   -    (204,835)
Net income (loss)   -    -    -    -    -    -    -    -    (854,143)   1,780    (852,363)
Balance, September 30, 2025   252,192   $252    1,859,231,786   $1,859,231   $103,724,675    8,501,503   $(137,261)  $(23,218)  $(88,785,741)  $10,644   $16,648,582 
                                                        
Balance, December 31, 2025   252,192   $252    1,860,376,075   $1,860,375   $104,110,876    12,489,710   $(246,898)  $(23,218)  $(96,789,073)  $12,600   $8,924,914 
Common stock issued for services and other stock-based compensation   -    -    -    -    403,370    -    -    -    -    -    403,370 
Common stock repurchased and held as treasury stock   -    -    -    -    -    1,710,963    (44,624)   -    -    -    (44,624)
Dividends   -    -    -    -    -    -    -    -    (204,835)   -    (204,835)
Net income (loss)   -    -    -    -    -    -    -    -    (3,892,031)   2,963    (3,889,068)
Balance, March 31, 2026   252,192   $252    1,860,376,075   $1,860,375   $104,514,246    14,200,673   $(291,522)  $(23,218)  $(100,885,939)  $15,563   $5,189,757 
Common stock issued for services and other stock-based compensation   -    -    -    -    (156,817)   -    -    -    -    -    (156,817)
Common stock repurchased and held as treasury stock   -    -    -    -    -    1,152,079    (25,420)   -    -    -    (25,420)
Dividends   -    -    -    -    -    -    -    -    (204,835)   -    (204,835)
Net income (loss)   -    -    -    -    -    -    -    -    (3,213,828)   (613)   (3,214,441)
Balance, June 30, 2026   252,192   $252    1,860,376,075   $1,860,375   $104,357,429    15,352,752   $(316,942)  $(23,218)  $(104,304,602)  $14,950   $1,588,244 
Common stock issued for services and other stock-based compensation   -    -    -    -    37,036    -    -    -    -    -    37,036 
Common stock repurchased and held as treasury stock   -    -    -    -    -    1,958,841    (35,669)   -    -    -    (35,669)
Dividends   -    -    -    -    -    -    -    -    (204,835)   -    (204,835)
Net income (loss)   -    -    -    -    -    -    -    -    8,993,099    (147)   8,992,952 
Balance, September 30, 2026   252,192   $252    1,860,376,075   $1,860,375   $104,394,465    17,311,593   $(352,611)  $(23,218)  $(95,516,338)  $14,803   $10,377,728 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

5

 

 

INVESTVIEW, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

   2026   2025 
   Nine Months Ended September 30, 
   2026   2025 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net income (loss)  $2,500,306   $128,001 
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:          
Depreciation   154,182    121,667 
Amortization of debt discount   252,632    252,632 
Stock issued for services and other stock-based compensation   283,589    1,164,355 
Lease cost, net of repayment   110    (101)
(Gain) loss on fair value of derivative liability   -    (133)
(Gain) loss on investment   (9,588,570)   - 
Change in fair value of digital assets   (19,100)   (399,029)
Realized (gain) loss on digital assets   89,728    (77,006)
Digital assets collected for membership revenue   (93,733)   (1,015,276)
Operating expenses paid with digital assets   252,995    1,462,694 
Changes in operating assets and liabilities:          
Receivables   325,913    (148,024)
Inventory   (181,969)   (598,358)
Prepaid assets   (38,814)   104,864 
Income tax paid in advance   106,289    - 
Deposits   940    (208,325)
Accounts payable and accrued liabilities   (485,521)   (278,532)
Income tax payable   (109,344)   (1,307)
Deferred revenue   (551,790)   (838,768)
Accrued interest   14,918    14,054 
Accrued interest, related parties   676,377    676,377 
Net cash provided by (used in) operating activities - continuing   (6,410,862)   359,785 
Net cash provided by (used in) operating activities - discontinuing   (716,546)   (3,465,671)
Net cash provided by (used in) operating activities   (7,127,408)   (3,105,886)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of digital assets   (357,522)   (4,815,947)
Proceeds from sale of digital assets   943,807    4,911,971 
Cash received from sale of Dream SPV investment   12,838,570    - 
Cash paid for Dream SPV investment   (2,000,000)   - 
Cash paid for fixed assets   (137,304)   (514,716)
Net cash provided by (used in) investing activities - continuing   11,287,551    (418,692)
Net cash provided by (used in) investing activities - discontinuing   9,858    - 
Net cash provided by (used in) investing activities   11,297,409    (418,692)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Repayments for related party debt   (675,387)   (675,387)
Repayments for debt   (30,216)   (21,933)
Proceeds from debt   80,000    - 
Purchase of Treasury Stock   (105,713)   (137,261)
Payments for shares repurchased from former related parties   -    (2,528,820)
Dividends paid   (487,853)   (499,275)
Net cash provided by (used in) financing activities - continuing   (1,219,169)   (3,862,676)
Net cash provided by (used in) financing activities - discontinuing   -    - 
Net cash provided by (used in) financing activities   (1,219,169)   (3,862,676)
           
Net increase (decrease) in cash and cash equivalents   2,950,832    (7,387,254)
Cash and cash equivalents - beginning of period   9,992,443    22,467,710 
Cash and cash equivalents - end of period  $12,943,275   $15,080,456 
           
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:          
Cash paid during the period for:          
Interest  $705,603   $697,320 
Income taxes  $57,530   $8,000 
Non-cash investing and financing activities - continuing:          
Digital assets collected for deferred coffee sales  $5,607   $- 
Dividends declared  $614,505   $614,505 
Dividends paid with digital assets  $134,535   $121,200 
Cumulative effect adjustment upon adoption of ASU 2023-08  $-   $148,346 
Non-cash investing and financing activities - discontinuing:          
Digital assets received from sale of fixed assets  $23,520   $144,478 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

6

 

 

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF SEPTEMBER 30, 2026

(Unaudited)

 

NOTE 1 – ORGANIZATION AND NATURE OF BUSINESS

 

Organization

 

Investview, Inc. was incorporated on January 30, 1946, under the laws of the state of Utah as the Uintah Mountain Copper Mining Company. In January 2005, we changed domicile to Nevada and changed our name to Voxpath Holding, Inc. In September of 2006, we merged with The Retirement Solution Inc. and then changed our name to TheRetirementSolution.Com, Inc. Subsequently, in October 2008 we changed our name to Global Investor Services, Inc., before changing our name to Investview, Inc., on March 27, 2012.

 

Effective April 1, 2017, we closed on a Contribution Agreement with the members of Wealth Generators, LLC, a limited liability company (“Wealth Generators”), pursuant to which the Wealth Generators members contributed 100% of the outstanding securities of Wealth Generators in exchange for an aggregate of 1,358,670,942 shares of our common stock. Following this transaction, Wealth Generators became our wholly owned subsidiary, and the former members of Wealth Generators became our stockholders and controlled the majority of our outstanding common stock.

 

On June 6, 2017, we entered into an Acquisition Agreement with Market Trend Strategies, LLC, a company whose members are also former members of our management. Under the Acquisition Agreement, we spun off our operations that existed prior to the merger with Wealth Generators and sold the intangible assets used in those pre-merger operations in exchange for Market Trend Strategies’ assumption of $419,139 in pre-merger liabilities.

 

On February 28, 2018, we filed a name change for Wealth Generators, LLC to Kuvera, LLC (“Kuvera”).

 

On January 17, 2019, we renamed our non-operating wholly owned subsidiary WealthGen Global, LLC to SAFETek, LLC, a Utah limited liability company.

 

On January 11, 2021, we filed a name change for Kuvera, LLC to iGenius, LLC (“iGenius”) and on February 2, 2021, we filed a name change for Kuvera (N.I.) Limited to iGenius Global LTD.

 

On September 20, 2021, the Board of Directors approved a change in our fiscal year from March 31 to December 31.

 

On February 19, 2026, we changed the name of our wholly-owned subsidiary iGenius, LLC to Conectiv LLC to reflect a strategic shift from focusing solely on financial education to a broader, more comprehensive ecosystem that includes health, wellness, and lifestyle products.

 

On July 8, 2026, the Company discontinued operations of its subsidiary SAFETek, LLC.

 

Nature of Business

 

We operate a diversified series of business units across key sectors, including a direct-to-consumer (“DTC”) marketing platform designed to promote, sell, and distribute its products and services through a global network of independent distributors directly to end users without reliance on traditional retail intermediaries; a manufacturing, marketing, and sales division focused on proprietary over-the-counter aesthetics, health, nutrition and cognitive wellness products for distribution across wholesale and retail markets through our DTC marketing platform and otherwise; and an early-stage online trading platform that intends to offer self-directed retail brokerage services. A bitcoin mining business that we previously operated through the first week of July 2026 has been terminated and those operations have been discontinued.

 

7

 

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Accounting

 

Our policy is to prepare our financial statements on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America.

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations (Regulation S-X) of the Securities and Exchange Commission (the “SEC”) and with the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The results of operations for the nine months ended September 30, 2026, are not necessarily indicative of the operating results that may be expected for our year ending December 31, 2026, as will be included in the filing of our Annual Report on Form 10-K for the year ending December 31, 2026. These unaudited condensed consolidated financial statements should be read in conjunction with the December 31, 2025 consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2025.

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of Investview, Inc., and our wholly owned subsidiaries: Conectiv LLC, SAFETek, LLC, Investview Financial Group Holdings, LLC, Opencash Finance, Inc., Opencash Securities, LLC, Investview MTS, LLC, myLife Wellness Company, myLife Wellness LLC, and Renu Laboratories LLC. The Company also owns 50% of ELRT Technologies, LLC, which has been included in the consolidated financial statements, and the Company has recorded a noncontrolling interest for the interest that it does not own. All intercompany transactions and balances have been eliminated in consolidation.

 

Discontinued Operations

 

The Company follows the provisions of ASC 205-20, Presentation of Discontinued Operations, which requires separate reporting if a component of the company is disposed of or is classified as held for sale. In order to recognize discontinued operation, a major product line or division of an entity must be both a component and a strategic shift in operations. The Company assessed its digital asset mining business and determined it met the criteria of ASC 205-20. We disclosed our discontinued operations separately in the condensed consolidated balance sheets, statements of operations and other comprehensive income (loss), and statements of cash flows as discontinued operations. See NOTE 13 – DISCONTINUED OPERATIONS.

 

Operating Segments

 

Operating segments are defined as components of an entity for which separate financial information is available that is regularly reviewed by the chief operating decision maker (“CODM”). The CODM is composed of several members of its executive management team, including the Chief Executive Officer, President and Chief Operating Officer, and the Chief Financial Officer. The CODM uses segment net income from operations to assess the performance of, manage the operations of, and allocate capital and operational resources to the Company’s two reportable operating segments.

 

Financial Statement Reclassification

 

Certain account balances from prior periods have been reclassified in these consolidated financial statements to conform to current period classifications.

 

Use of Estimates

 

The preparation of these financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

8

 

 

Concentration of Credit Risk

 

Financial instruments that potentially expose us to concentration of credit risk include cash, accounts receivable, and advances. We place our cash and temporary cash investments with credit quality institutions. At times, such investments may be in excess of the Federal Deposit Insurance Corporation (“FDIC”) insurance limit of $250,000. As of September 30, 2026 and December 31, 2025, cash balances that exceeded FDIC limits were $11,819,874 and $8,115,922, respectively. We have not experienced significant losses relating to these concentrations in the past.

 

Cash Equivalents

 

For purposes of reporting cash flows, we consider all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. As of September 30, 2026, and December 31, 2025, we had no cash equivalents.

 

Receivables

 

Receivables are carried at net realizable value, representing the outstanding balance less an allowance for doubtful accounts based on a review of all outstanding amounts. Management determines the allowance for doubtful accounts by regularly evaluating individual receivables and receivables are written off when deemed uncollectible. Recoveries of receivables previously written off are recorded when received.

 

Receivables were made up of the following as of each balance sheet date:

 

   September 30,   December 31, 
   2026   2025 
Due from merchant processors  $90,477   $61,779 
Held in reserve by merchant processors for future returns and chargebacks   20,514    22,309 
Due from payout service providers   86,927    109,367 
Accounts and other receivables   35,248    362,929 
Receivable, gross    233,166    556,384 
Allowance for doubtful accounts   (2,695)   - 
Receivables   $230,471   $556,384 

 

Fixed Assets

 

Fixed assets are stated at cost and depreciated using the straight-line method over their estimated useful lives. When retired or otherwise disposed, the carrying value and accumulated depreciation of the fixed asset is removed from its respective accounts and the net difference less any amount realized from disposition is reflected in earnings. Expenditures for maintenance and repairs, which do not extend the useful lives of the related assets, are expensed as incurred.

 

Fixed assets were made up of the following at each balance sheet date:

 

   Estimated         
   Useful         
   Life   September 30,   December 31, 
   (years)   2026   2025 
Furniture, fixtures, and equipment   10   $13,108   $13,108 
Computer equipment   3    34,404    32,021 
Manufacturing equipment   3-25    1,810,914    1,675,993 
Gross book value         1,858,426    1,721,122 
Accumulated depreciation        (350,574)   (196,392)
Net book value       $1,507,852   $1,524,730 

 

9

 

 

Total depreciation expense for the nine months ended September 30, 2026 and 2025, was $154,182 and $121,667, respectively.

 

Digital Assets

 

Digital assets are included in non-current assets on the Consolidated Balance Sheets due to the Company’s intent to retain and hold bitcoin. Proceeds from the sale of digital assets and the purchase of digital assets are included within investing activities in the accompanying Consolidated Statement of Cash Flows. Digital Assets awarded to the Company through its mining activities and collected for membership revenue are accounted for in connection with the Company’s revenue recognition policy. Following the adoption of Accounting Standards Update (“ASU”) 2023-08 effective January 1, 2025, the Company measures digital assets at fair value with changes recognized in other income (expense) in the Consolidated Statement of Operations. The Company tracks its cost basis of digital assets by-wallet in accordance with the first-in-first-out (“FIFO”) method of accounting. Refer to “NOTE 5 – DIGITAL ASSETS”, for further information regarding the Company’s impact of the adoption of ASU 2023-08, as defined below.

 

Equity investments without readily determinable fair values

 

Equity investments without readily determinable fair values are accounted for under the measurement alternative. Under the measurement alternative, the carrying value is measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. Changes in value and impairments of equity investments without readily determinable fair values are recognized in “Gain (loss) on investment” in our condensed consolidated statement of operations. Equity investments without readily determinable fair values are presented as “Equity investment” in our consolidated balance sheet (see NOTE 12).

 

Goodwill

 

Goodwill represents the excess of the purchase price over the fair value of the net assets acquired in a business combination. Goodwill is not subject to amortization, and instead, assessed for impairment annually at the end of each fiscal year, or more frequently when events or changes in circumstances indicate that it is more likely than not that the fair value of a reporting unit is less than its carrying amount in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 350 - Intangibles - Goodwill and Other.

 

The Company has the option to first assess qualitative factors to determine whether events or circumstances indicate it is more likely than not that the fair value of a reporting unit is greater than its carrying amount, in which case a quantitative impairment test is not required.

 

As provided for by ASU No. 2017-04, Simplifying the Test for Goodwill Impairment, the quantitative goodwill impairment test is performed by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not impaired. An impairment loss is recognized for any excess of the carrying amount of the reporting unit over its fair value up to the amount of goodwill allocated to the reporting unit.

 

On October 11, 2024, through a wholly owned subsidiary, the Company closed on the purchase of the business and assets of Renu Labs, a manufacturer of proprietary and other health, beauty, and wellness products. The transaction was accounted for as a business combination using the acquisition method of accounting in accordance with the ASC Topic 805 which resulted in $873,701 of goodwill. During the year ended December 31, 2025, this goodwill was fully impaired.

 

Intangible Assets

 

We account for our intangible assets in accordance with FASB ASC Subtopic 350-30, General Intangibles Other Than Goodwill (“ASC 350-30”), and ASC Subtopic 360-10-05, Accounting for the Impairment or Disposal of Long-Lived Assets (“ASC 360-10-05”). ASC 350-30 requires assets to be measured based on the fair value of the consideration given or the fair value of the assets (or net assets) acquired, whichever is more clearly evident and, thus, more reliably measurable. Under ASC 350-30 any intangible asset with a useful life is required to be amortized over that life and the useful life is to be evaluated every reporting period to determine whether events or circumstances warrant a revision to the remaining period of amortization. If the estimate of useful life is changed the remaining carrying amount of the intangible asset is amortized prospectively over the revised remaining useful life. Costs of internally developing, maintaining, or restoring intangible assets are recognized as an expense when incurred.

 

10

 

 

Impairment of Long-Lived Assets

 

We have adopted ASC Subtopic 360-10, Property, Plant and Equipment (“ASC 360-10”). ASC 360-10 requires that long-lived assets and certain identifiable intangibles held and used by us be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable or when the historical cost carrying value of an asset may no longer be appropriate. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period.

 

We evaluate the recoverability of long-lived assets based upon future net cash flows expected to result from the asset, including eventual disposition. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted and an impairment loss is recorded equal to the difference between the asset’s carrying value and fair value or disposable value. During the nine months ended September 30, 2026 and 2025, no impairment was recorded.

 

Fair Value of Financial Instruments

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on our principal or, in the absence of a principal, most advantageous market for the specific asset or liability.

 

U.S. generally accepted accounting principles provide for a three-level hierarchy of inputs to valuation techniques used to measure fair value, defined as follows:

 

  Level 1: Inputs that are quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity can access.
     
  Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability, including:

 

  - quoted prices for similar assets or liabilities in active markets;
  - quoted prices for identical or similar assets or liabilities in markets that are not active;
  - inputs other than quoted prices that are observable for the asset or liability; and
  - inputs that are derived principally from or corroborated by observable market data by correlation or other means.

 

  Level 3: Inputs that are unobservable and reflect management’s own assumptions about the inputs market participants would use in pricing the asset or liability based on the best information available in the circumstances (e.g., internally derived assumptions surrounding the timing and amount of expected cash flows).

 

Our financial instruments consist of cash, accounts receivable and accounts payable, and debt. We have determined that the book value of our outstanding financial instruments as of September 30, 2026, and December 31, 2025, approximates the fair value due to their short-term nature or interest rates.

 

Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of September 30, 2026:

 

   Level 1   Level 2   Level 3   Total 
Digital assets (see NOTE 5)  $5,664,813   $-   $-   $5,664,813 
Total Assets  $5,664,813   $-   $-   $5,664,813 
                     
Total Liabilities  $-   $-   $-   $- 

 

11

 

 

Items recorded or measured at fair value on a recurring basis in the accompanying consolidated financial statements consisted of the following items as of December 31, 2025:

 

   Level 1   Level 2   Level 3   Total 
Digital assets (see NOTE 5)  $5,464,011   $-   $-   $5,464,011 
Total Assets  $5,464,011   $-   $-   $5,464,011 
                     
Total Liabilities  $-   $-   $-   $- 

 

Revenue Recognition

 

Membership Revenue

 

Most of our revenue is generated by membership sales and payment is received at the time of purchase. In some cases, customers use earned commissions to pay or partially pay for a membership. We recognize membership revenue in accordance with ASC Subtopic 606-10, Revenue from Contracts with Customers (“ASC 606-10”), where revenue is measured based on a consideration specified in a contract with a customer and recognized when we satisfy the performance obligation specified in each contract. Our performance obligation is to provide our tools, products, and content over a fixed membership period; therefore, we recognize revenue ratably over the membership period and deferred revenue is recorded for the portion of the membership period subsequent to each reporting date. Additionally, we offer a designated trial period to first-time membership customers, during which a full refund can be requested if a customer does not wish to continue with the membership. Revenues are deferred during the trial period as collection is not probable until that time has passed. Revenues are presented net of refunds, sales incentives, credits, and known and estimated credit card chargebacks. As of September 30, 2026, and December 31, 2025, our deferred revenues for membership revenue were $299,254 and $821,903, respectively.

 

Health and Wellness Product Sales and Other Revenue

 

Through our wholly owned subsidiary, Renu Laboratories LLC, we generate revenue by manufacturing and selling health, beauty, and wellness products. We recognize health and wellness product sales revenue in accordance with ASC 606-10. The Company’s performance obligation is complete when control of the promised goods is transferred to a customer, at which time the Company recognizes revenue in an amount that reflects the consideration the Company expects to receive in exchange for those goods. The Company terms for the sale are based on free on board (FOB) shipping point, where the control passes to the customer once the product leaves our warehouse. The Company determines collectability by requiring certain customers to pay before control is transferred and by performing ongoing credit evaluations and monitoring customer accounts receivable balances. As of September 30, 2026, and December 31, 2025, deposits collected from customers for orders to be filled at a future date were $76,207 and $108,061, respectively, which are recorded as deferred revenue in the Consolidated Balance Sheets.

 

Shipping and direct costs charged to customers, along with fees collected from customers for storing their products in our warehouse facility located in Warminster, Pennsylvania are included in revenue as Other Revenue. Shipping and direct costs incurred by the Company are included in Cost of Sales and Service.

 

Coffee Sales

 

In January 2026, the Company started selling a proprietary brand of coffee. The Company’s performance obligation is to deliver the coffee to customers. Therefore, revenue is recognized once delivery occurs. Customers remit payment at the time of order placement, therefore payment received by the Company prior to coffee delivery is recorded as deferred revenue. As of September 30, 2026, the Company had $6,352 of deferred revenue for its coffee sales. Shipping and handling costs that occur are paid by the customer and are recorded as revenue. The Company has a policy to provide a refund on any product returned by the customer.

 

12

 

 

Revenue generated for the three months ended September 30, 2026, was as follows:

 

   Membership
revenue
   Health and wellness product sales   Coffee Sales   Other Revenue   Total 
Gross billings/receipts  $1,933,562   $238,372   $178,678   $3,084   $2,353,696 
Refunds, incentives, credits, and chargebacks   (114,074)   -    (1,042)   -    (115,116)
Net revenue  $1,819,488   $238,372   $177,636   $3,084   $2,238,580 

 

Foreign revenues for the three months ended September 30, 2026 were approximately $0.5 million while domestic revenue for the three months ended September 30, 2026 was approximately $1.7 million.

 

Revenue generated for the three months ended September 30, 2025, was as follows:

 

   Membership revenue   Health and wellness product sales   Other Revenue   Total 
Gross billings/receipts  $7,526,954   $1,041,851   $32,598   $8,601,403 
Refunds, incentives, credits, and chargebacks   (460,220)   (12,178)   -    (472,398)
Net revenue  $7,066,734   $1,029,673   $32,598   $8,129,005 

 

Foreign revenues for the three months ended September 30, 2025, were approximately $6.0 million while domestic revenue for the three months ended September 30, 2025 was approximately $2.1 million.

 

Revenue generated for the nine months ended September 30, 2026, was as follows:

 

   Membership
revenue
   Health and wellness product sales   Coffee Sales   Other Revenue   Total 
Gross billings/receipts  $6,970,999   $751,409   $661,489   $15,263   $8,399,160 
Refunds, incentives, credits, and chargebacks   (311,116)   (1,713)   (31,348)   -    (344,177)
Net revenue  $6,659,883   $749,696   $630,141   $15,263   $8,054,983 

 

Foreign revenues for the nine months ended September 30, 2026 were approximately $2.8 million while domestic revenue for the nine months ended September 30, 2026 was approximately $5.3 million.

 

Revenue generated for the nine months ended September 30, 2025, was as follows:

 

   Membership revenue   Health and wellness product sales   Other Revenue   Total 
Gross billings/receipts  $25,166,094   $2,722,041   $78,249   $27,966,384 
Refunds, incentives, credits, and chargebacks   (1,463,235)   (12,349)   -    (1,475,584)
Net revenue  $23,702,859   $2,709,692   $78,249   $26,490,800 

 

13

 

 

Foreign revenues for the nine months ended September 30, 2025, were approximately $20.5 million while domestic revenue for the nine months ended September 30, 2025 was approximately $6.0 million.

 

Advertising, Selling and Marketing Costs

 

We expense advertising, selling, and marketing costs as incurred. Advertising, selling, and marketing costs include costs of promoting our product worldwide, including promotional events. Advertising, selling, and marketing expenses for the nine months ended September 30, 2026, and 2025, totaled $334,216 and $543,214, respectively.

 

Cost of Sales and Service

 

Included in our costs of sales and services are mainly amounts paid to our trading and market experts that provide financial education content and tools to our membership customers, the raw material and manufacturing costs of our health and wellness product sales, and the coffee costs for our coffee sales. Costs of sales and services for the nine months ended September 30, 2026 and 2025, totaled $1,148,580 and $3,017,091, respectively.

 

Inventory

 

Inventory consists of raw materials, work in progress, and finished goods to be sold as part of our health and wellness product sales. Inventory is valued at the lower of cost or net realizable value using the first-in, first-out (FIFO) method and is inclusive of any shipping and tax costs.

 

Inventory was made up of the following at each balance sheet date:

 

   September 30,   December 31, 
   2026   2025 
Finished goods  $345,153   $38,664 
Work in process   21,283    115,733 
Raw materials   478,533    508,603 
Inventory  $844,969   $663,000 

 

Income Taxes

 

Income taxes are recorded in accordance with ASC Topic 740, Income Taxes, which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between financial statements and tax basis of assets and liabilities, including operating losses and credit carryforwards, using enacted tax rates in effect for the year in which the differences are expected to reverse.

 

Management judgment is required in determining our provision for income taxes, our deferred tax assets and liabilities, and any valuation allowance recorded against our deferred tax assets. Deferred tax assets are reduced by a valuation allowance if, based on the consideration of all available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. Changes in assumptions in future periods may require we adjust our valuation allowance, which could materially impact our financial position and results of operations. The Company recognizes the benefit of an uncertain tax position that it has taken or expects to take on its income tax return, if such a position is more likely than not to be sustained.

 

Net Income (Loss) per Share

 

We follow ASC Subtopic 260-10, Earnings per Share, which specifies the computation, presentation, and disclosure requirements of earnings per share information. Basic loss per share has been calculated based upon the weighted average number of common shares outstanding. Diluted income (loss) per share reflects the potential dilution that could occur if stock options or other contracts to issue common stock were exercised or converted during the period. Dilutive securities having an anti-dilutive effect on diluted earnings per share are excluded from the calculation.

 

Due to the net loss of continued and discontinued operations for the three months ended September 30, 2025, basic and diluted income per share were the same, as all securities had an anti-dilutive effect.

 

14

 

 

The following table presents potentially dilutive securities that were not included in the computation of diluted net income of continued and discontinued operations per share for the three months ended September 30, 2025, as their inclusion would be anti-dilutive.

 

Weighted average options to purchase common stock   351,416,665 
Weighted average warrants to purchase common stock   1,002,720 
Common stock issuable upon conversion of notes   471,428,571 
Common stock issuable upon conversion of non-voting membership interest   565,000,000 

 

The following table illustrates the computation of diluted earnings per share of continued operations for the three months ended September 30, 2026.

 

      
Net income from continued operations  $8,878,194 
Less: net income attributable to noncontrolling interest   147 
Less: preferred dividends   (204,835)
Add: interest expense on convertible debt   225,129 
Net income from continued operations available to common shareholders (numerator)  $8,898,635 
      
Basic weighted average number of common shares outstanding   1,844,159,552 
Dilutive impact of convertible notes   471,428,571 
Dilutive impact of non-voting membership interest   563,855,711 
Diluted weighted average number of common shares outstanding (denominator)   2,879,443,834 
      
Diluted income from continued operations per common share  $0.00 

 

The following table presents potentially dilutive securities that were not included in the computation of diluted net income of continued operations per share for the three months ended September 30, 2026, as their inclusion would be anti-dilutive.

 

      
Weighted average options to purchase common stock   316,568,839 

 

The following table illustrates the computation of diluted earnings per share of discontinued operations for the three months ended September 30, 2026.

 

      
Net income from discontinued operations  $114,758 
Less: net income attributable to noncontrolling interest   147 
Less: preferred dividends   (204,835)
Add: interest expense on convertible debt   225,129 
Net income from continued operations available to common shareholders (numerator)  $135,199 
      
Basic weighted average number of common shares outstanding   1,844,159,552 
Dilutive impact of convertible notes   471,428,571 
Dilutive impact of non-voting membership interest   563,855,711 
Diluted weighted average number of common shares outstanding (denominator)   2,879,443,834 
      
Diluted income from continued operations per common share  $0.00 

 

15

 

 

The following table presents potentially dilutive securities that were not included in the computation of diluted net income of discontinued operations per share for the three months ended September 30, 2026, as their inclusion would be anti-dilutive.

 

      
Weighted average options to purchase common stock   316,568,839 

 

Due to the net loss of discontinued operations for the nine months ended September 30, 2026 and the net loss of discontinued operations for the nine months ended September 30, 2025, basic and diluted income per share were the same, as all securities had an anti-dilutive effect.

 

The following table presents potentially dilutive securities that were not included in the computation of diluted net income of discontinued operations per share for the nine months ended September 30, 2026 and the net loss of discontinued operations for the nine months ended September 30, 2025, as their inclusion would be anti-dilutive.

 

   September 30, 2026   September 30, 2025 
Weighted average options to purchase common stock   353,044,504    361,416,665 
Weighted average warrants to purchase common stock   361,933    1,118,991 
Common stock issuable upon conversion of notes   471,428,571    471,428,571 
Common stock issuable upon conversion of non-voting membership interest   563,855,711    565,000,000 

 

The following table illustrates the computation of diluted earnings per share of continued operations for the nine months ended September 30, 2026 and 2025.

 

   September 30, 2026   September 30, 2025 
Net income from continued operations  $2,500,306   $128,001 
Less: net income attributable to noncontrolling interest   (2,203)   (2,574)
Less: preferred dividends   (614,505)   (614,505)
Add: interest expense on convertible debt   675,387    675,387 
Net income from continued operations available to common shareholders (numerator)  $2,558,985   $186,309 
           
Basic weighted average number of common shares outstanding   1,845,558,194    1,856,658,888 
Dilutive impact of convertible notes   471,428,571    471,428,571 
Dilutive impact of non-voting membership interest   563,855,711    565,000,000 
Diluted weighted average number of common shares outstanding (denominator)   2,880,842,476    2,893,087,459 
           
Diluted income from continued operations per common share  $0.00   $0.00 

 

The following table presents potentially dilutive securities that were not included in the computation of diluted net income of continued operations per share for the nine months ended September 30, 2026 and 2025, as their inclusion would be anti-dilutive.

 

   September 30, 2026   September 30, 2025 
Weighted average options to purchase common stock   353,044,504    361,416,665 
Weighted average warrants to purchase common stock   361,933    1,118,991 

 

16

 

 

Lease Obligation

 

We determine if an arrangement is a lease at inception. Operating leases are included in the operating lease right-of-use asset account, the operating lease liability, current account, and the operating lease liability, long-term account in our balance sheet. Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease.

 

Operating lease right-of-use assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. For leases in which the rate implicit in the lease is not readily determinable, we use our incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. We have elected not to apply the recognition requirements of ASC Topic 842, Leases, to short-term leases (leases with terms of twelve months or less). Lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for operating lease arrangements is recognized on a straight-line basis over the lease term. We have elected the practical expedient and will not separate non-lease components from lease components and will instead account for each separate lease component and non-lease component associated with the lease components as a single lease component.

 

NOTE 3 – RECENT ACCOUNTING PRONOUNCEMENTS

 

In December 2023, the FASB issued ASU No. 2023-08, Intangibles—Goodwill and Other—Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets (“ASU 2023-08”). The amendments in ASU 2023-08 are intended to improve the accounting for certain crypto assets by requiring an entity to measure those crypto assets at fair value each reporting period with changes in fair value recognized in net income. The amendments also improve the information provided to investors about an entity’s crypto asset holdings by requiring disclosure about significant holdings, contractual sale restrictions, and changes during the reporting period. The amendments are effective for all entities for fiscal years beginning after December 15, 2024, including interim periods within those fiscal years. The Company adopted ASU 2023-08 for the year ended December 31, 2025, effective as of January 1, 2025, which had a material impact on the financial statements.

 

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 expands existing income tax disclosures for rate reconciliations by requiring disclosure of certain specific categories and additional reconciling items that meet quantitative thresholds and expands disclosures for income taxes paid by requiring disaggregation by certain jurisdictions. ASU 2023-09 is effective for annual periods beginning after December 15, 2024; early adoption is permitted. The Company adopted ASU 2023-09 for the year ended December 31, 2025. The amendments only impact disclosures and did not have an impact on the Company’s financial condition and results of operations.

 

In November 2024, the FASB issued ASU No. 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40) (“ASU 2024-03”). ASU 2024-03 requires, in the notes to the financial statements, disclosures of specified information about certain costs and expenses specified in the updated guidance. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company did not elect early adoption and is evaluating the impact the updated guidance will have on its disclosures in 2027.

 

We have noted no other recently issued accounting pronouncements that we have not yet adopted that we believe are applicable or would have a material impact on our financial statements.

 

NOTE 4 – LIQUIDITY

 

During the nine months ended September 30, 2026, we recorded a net loss from operations of $6,356,253, net income from continued operations of $2,500,306, and a net income of $1,889,443. During that period, we were able to meet our short- and long-term working capital needs and capital expenditure requirements through our available cash and liquid assets.

 

17

 

 

The Company’s capital is generally used to support operations and capital expenditures. However, the Company also, from time-to-time, will review potential investments that it believes present unique situations to participate in growth opportunities. Two such opportunities presented themselves when the Company, during October 2025 and March 2026, invested an aggregate of $3.25 million in a special purpose vehicle (the “SPV”) organized by Dream Ventures LLC, which participated in exempt private placements in an early-stage enterprise developing next-generation nuclear power and infrastructure technologies. The Company’s investment consisted of the acquisition of restricted units of the SPV valued at the time of the investments at $3.25 million. We did not possess a controlling financial interest or exercise significant influence over the SPV, and any proposed transfer of our restricted units requires prior written consent of the SPV.

 

Although the Company is not in the business of making investments in private securities, these investments were viewed by the Board of Directors as a strategic investment intended to access a possible growth opportunity that takes advantage of renewed momentum around modular, rapidly deployable energy systems, supported by recent federal initiatives and Department of Energy programs promoting advanced-reactor innovation. Ultimately, during the nine months ended September 30, 2026, we sold our $3.3 million investment for $12.8 million and recognized a $9.6 million gain.

 

At September 30, 2026, we had working capital of $9.6 million (including $12.9 million in cash and cash equivalents) largely through the sale of our investment in private securities, and a digital asset balance at a fair value of $5.7 million. These amounts were sufficient to sustain our losses from operations during the first nine months of the year. We do not believe that our operating losses will continue at this level for the longer term since during 2026 we have implemented initiatives to, among others, expand our direct selling network, diversify our revenue base, transition our direct-to-consumer business unit toward a more diversified operating platform, wind-down our bitcoin mining operations in July 2026, and implement broad-based cost-cutting initiatives. Despite our expectations, our operations have not yet reflected any such expected improvement. We still, however, believe that we will be able to sustain our operations for at least the next twelve months since through September 30 2026, we were able to monetize our private investments, and at amounts that significantly appreciated above our purchase price. See “NOTE 12 – EQUITY INVESTMENT.”

 

NOTE 5 – DIGITAL ASSETS

 

Adoption of ASU No. 2023-08, Accounting for and Disclosure of Crypto Assets

 

Effective January 1, 2025, the Company adopted ASU 2023-08, which requires entities to measure crypto assets at fair value with changes recognized in the Statement of Operations each reporting period. The Company’s digital assets are within the scope of ASU 2023-08, and the transition guidance requires a cumulative-effect adjustment as of the beginning of the fiscal year of adoption for any difference between the carrying amount of the Company’s digital assets and fair value. As a result of the Company’s adoption of ASU 2023-08, the Company recorded a $148,346 increase to digital assets and a $148,346 decrease to accumulated deficit on the Balance Sheets as of the beginning of the fiscal year ended December 31, 2025.

 

The following table presents the Company’s Digital Asset holdings as of September 30, 2026:

 

   Quantity   Cost Basis   Fair Value 
Bitcoin   67.02   $6,172,684   $5,599,870 
USDC   49,295    49,295    49,295 
USDT   15,648    15,648    15,648 
Total digital assets held as of September 30, 2026       $6,237,627   $5,664,813 

 

18

 

 

The following table presents a roll-forward of total digital assets for the nine months ended September 30, 2026, based on the fair value model under ASU 2023-08:

 

   Fair Value 
Balance as of December 31, 2025  $5,464,011 
Revenue recognized from Bitcoin mined (15.34 Bitcoin)   1,152,156 
Digital assets collected from membership revenue   93,733 
Digital assets collected for deferred coffee sales   5,607 
Purchase of digital assets   357,522 
Digital assets received from sale of fixed assets   23,520 
Proceeds from sale of digital assets   (943,807)
Operating expenses paid with digital assets   (280,241)
Dividends paid via digital assets   (134,535)
Realized gain (loss) on digital assets   (92,253)
Change in fair value of digital assets   19,100 
Balance as of September 30, 2026  $5,664,813 

 

The following table presents a roll-forward of total digital assets for the nine months ended September 30, 2025, based on the fair value model under ASU 2023-08:

 

   Fair Value 
Balance as of December 31, 2024  $1,127,891 
Cumulative effect adjustment upon adoption of ASU 2023-08   148,346 
Revenue recognized from Bitcoin mined (25.20 Bitcoin)   2,615,778 
Digital assets collected from membership revenue   1,015,276 
Digital assets received from sale of fixed assets   144,478 
Purchase of digital assets   4,815,947 
Proceeds from sale of digital assets   (4,911,971)
Operating expenses paid with digital assets   (1,516,078)
Dividends paid via digital assets   (121,200)
Realized gain (loss) on digital assets   77,006 
Change in fair value of digital assets   399,029 
Balance as of September 30, 2025  $3,794,502 

 

NOTE 6 – RELATED-PARTY TRANSACTIONS

 

Related Party Debt

 

Our related-party payables consisted of the following:

 

   September 30, 2026   December 31, 2025 
Convertible Promissory Note entered into on 4/27/20, net of debt discount of $464,896 as of September 30, 2026 [1]  $835,104   $737,924 
Convertible Promissory Note entered into on 5/27/20, net of debt discount of $252,399 as of September 30, 2026 [2]   447,601    394,841 
Convertible Promissory Note entered into on 11/9/20, net of debt discount of $491,265 as of September 30, 2026 [3]   808,735    706,043 
Working Capital Promissory Note entered into on 3/22/21 [4]   1,206,877    1,205,887 
Total related-party debt   3,298,317    3,044,695 
Less: Current portion   (1,206,877)   (1,205,887)
Related-party debt, long term  $2,091,440   $1,838,808 

 

 

[1] On April 27, 2020, we received proceeds of $1,300,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 20% per annum, payable monthly, and the principal is due and payable on April 27, 2030. Per the original terms of the agreement, the note was convertible into common stock at a conversion price of $0.01257 per share, which was amended on November 9, 2020 to reduce the conversion price to $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $1,300,000. During the nine months ended September 30, 2026, we recognized $97,180 of the debt discount into interest expense, and expensed an additional $195,012 of interest expense on the note, all of which was repaid during the period.

 

19

 

 

[2] On May 27, 2020, we received proceeds of $700,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 20% per annum, payable monthly, and the principal is due and payable on April 27, 2030. Per the original terms of the agreement, the note was convertible into common stock at a conversion price of $0.01257 per share, which was amended on November 9, 2020 to reduce the conversion price to $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $700,000. During the nine months ended September 30, 2026, we recognized $52,760 of the debt discount into interest expense and expensed an additional $105,000 of interest expense on the note, all of which was repaid during the period.
   
[3] On November 9, 2020, we received proceeds of $1,300,000 from DBR Capital, LLC, an entity controlled by a member of our Board of Directors, and entered into a convertible promissory note. The note is secured by collateral of the Company and its subsidiaries. The note bears interest at 38.5% per annum, made up of a 25% interest rate per annum and a facility fee of 13.5% per annum, payable monthly beginning February 1, 2021, and the principal is due and payable on April 27, 2030. Per the terms of the agreement, the note is convertible into common stock at a conversion price of $0.007 per share. At inception we recorded a beneficial conversion feature and debt discount of $1,300,000. During the nine months ended September 30, 2026, we recognized $102,692 of the debt discount into interest expense and expensed an additional $375,374 of interest expense on the note, all of which was repaid during the period.
   
[4] On March 22, 2021, we entered into Securities Purchase Agreements to purchase 100% of the operating assets of SSA Technologies LLC, an entity that owns and operates a FINRA-registered broker-dealer. SSA is controlled and partially owned by Joseph Cammarata, our former Chief Executive Officer. (See Note 10). Commencing upon execution of the agreements and through the closing of the transactions, we agreed to provide certain transition service arrangements to SSA. In connection with the transactions, we entered into a Working Capital Promissory Note with SSA under which SSA was to have advanced to us up to $1,500,000 before the end of 2021; however, SSA only provided advances of $1,200,000, to date. The note bears interest at the rate of 0.11% per annum. The note was due and payable by January 31, 2022; however, has not yet been repaid as we consider our legal options in light of SSA’s failure to complete its funding obligations, and the other damages we sustained as a result of the actions of Mr. Cammarata. During the nine months ended September 30, 2026, we recorded interest expense of $990 on the note. The note was to have been secured by the pledge of 12,000,000 shares of our common stock; however, it remains unsecured as the pledge of shares was not implemented at the closing of the loan.

 

The loans referenced in footnotes 1-3 above were advanced under a Securities Purchase Agreement we entered into on April 27, 2020, with DBR Capital. Under the Securities Purchase Agreement (which was subsequently amended and restated), DBR Capital agreed to advance up to $11 million to us in a series of up to five closings through December 31, 2026, of which the amounts advanced covered in footnotes 1-3 above constituted the first three closings.

 

On February 28, 2025, we and DBR Capital entered into a Fifth Amendment to the now Amended and Restated Securities Purchase Agreement that extends the deadlines for the fourth and fifth closings under that Agreement from December 31, 2024, to August 31, 2025, and December 31, 2026, respectively. DBR Capital’s right to effect the fourth closing expired on August 31, 2025; however, the fifth closing remains at the sole discretion of DBR Capital, and we cannot provide any assurance that it will occur when contemplated or ever.

 

Other Related Party Arrangements

 

On September 29, 2023, we closed on the purchase in a private transaction of shares of our common stock under the terms of a Stock Purchase and Release Agreement dated September 18, 2023 (the “Romano/Raynor Agreement”). Under the Romano/Raynor Agreement, the Company purchased for surrender in a series of private transactions, an aggregate of 302,919,223 shares of the Company’s common stock (the “Romano/Raynor Purchased Shares”) from sellers consisting of Mario Romano, Annette Raynor, and a series of their family members and related entities (collectively, the “Sellers”). The Romano/Raynor Purchased Shares were purchased for aggregate consideration of $2,922,380, representing a price of $0.00964739 per share. One-eighth of the purchase price was paid within seven (7) days of the closing, with the balance payable in a series of equal quarterly payments over seven (7) consecutive quarters thereafter.

 

20

 

 

In addition to the cash consideration for the Purchased Shares, the Company also agreed to cover a limited amount of the legal fees incurred by the Sellers in the transaction, as well as provide Mr. Romano and Ms. Raynor with a $250,000 expense allowance, payable in installments, to cover legal fees and other expenses on a non-accountable basis, in connection with any matters that may arise in which either or both of Mr. Romano and/or Ms. Raynor served as officers and directors of the Company. In return, Mr. Romano and Ms. Raynor agreed to waive any future entitlement, if at all, to indemnification of costs and expenses, including legal fees under Nevada law or otherwise arising from or relating to any period in which Romano or Raynor were officers and directors of the Company.

 

The consideration paid for the Purchased Shares of $2,922,380 plus the $250,000 expense allowance was allocated to the share purchase for a total of $3,172,380.

 

On February 7, 2024, we closed on the purchase in a private transaction of shares of our common stock under the terms of a Stock Purchase and Release Agreement dated February 6, 2024 (the “Smith/Miller Agreement”). Under the Smith/Miller Agreement, the Company purchased for surrender and cancellation a total of 472,374,710 shares of the Company’s common stock (the “Smith/Miller Purchased Shares”) from Ryan Smith and Chad Miller and certain of their respective affiliates and family members. The Smith/Miller Purchased Shares were purchased for aggregate purchase price of $3,571,146, representing a price of $0.007559985 per share. One-eighth of the purchase price was paid within seven (7) days of the closing, with the balance payable in a series of equal quarterly payments over seven (7) consecutive quarters thereafter.

 

The consideration paid for the Purchased Shares of $3,571,146 was allocated to the share purchase.

 

The Romano/Raynor Agreement and the Smith/Miller Agreement were paid in full during the year ended December 31, 2025. During the nine months ended September 30, 2025, we made payments of $2,528,820 for shares repurchased under the Romano/Raynor Agreement and the Smith/Miller Agreement.

 

NOTE 7 – DEBT

 

Our debt consisted of the following:

 

   September 30,
2026
   December 31,
2025
 
Loan with the U.S. Small Business Administration dated 4/19/20 [1]  $501,490   $509,399 
Insurance policy loan [2]   72,611    - 
Total debt   574,101    509,399 
Less: current portion   101,855    29,244 
Debt, long term portion  $472,246   $480,155 

 

 

[1] In April 2020 we received proceeds of $500,000 from a loan entered into with the U.S. Small Business Administration. Under the terms of the loan interest is to accrue at a rate of 3.75% per annum and installment payments of $2,437 monthly will begin twelve months from the date of the loan, with all interest and principal due and payable thirty years from the date of the loan. During the nine months ended September 30, 2026, we recorded $14,024 worth of interest on the loan. During the nine months ended September 30, 2026, we made principal and interest payments on the loan of $21,933.
[2] In August 2026 we received proceeds of $80,000 from a loan entered into to cover insurance premiums. Under the terms of the loan interest is to accrue at a rate of 7.65% per annum and installment payments of $8,283 monthly will begin in September 2026. During the nine months ended September 30, 2026, we recorded $894 worth of interest on the loan. During the nine months ended September 30, 2026, we made principal and interest payments on the loan of $8,283.

 

21

 

 

NOTE 8 – OPERATING LEASE

 

In July 2021, we entered an operating lease for office space in Wyckoff, New Jersey (the “Wyckoff Lease”), and in September 2021 we assumed an operating lease for office space in Haverford, Pennsylvania (the “Haverford Lease”) in connection with the acquisition of all of the operating assets of MPower Trading Systems, LLC (“MPower”). This facility now serves as the headquarters of the company. In November 2024, we entered an operating lease for office, warehouse, and manufacturing space in Warminster, Pennsylvania (the “Warminster Lease”) and in December 2024, we entered an operating lease for warehouse space in Ivyland, Pennsylvania (the “Ivyland Lease”). The Warminster Lease and the Ivyland Lease were entered into for use by our subsidiary Renu Laboratories LLC.

 

At the commencement of the Wyckoff Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $22,034. The original 24.5-month term of the Wyckoff Lease was extended twice through July 2027 with an option for the Company to terminate with 60 days’ written notice beginning June 1, 2026. The earliest termination date is July 31, 2026. At the first extension of the Wyckoff Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $23,520. At the second extension of the Wyckoff Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $25,439.

 

At the date of acquisition of the Haverford Lease, right-of-use assets and lease liabilities obtained amounted to $125,522 and $152,961, respectively. The term of the Haverford Lease was initially extended through December 2024. At the extension of the Haverford Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $172,042. On September 26, 2025, the term of the Haverford Lease was extended through December 31, 2026.

 

At the commencement of the Warminster Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $108,327. The term of the Warminster Lease was extended through December 31, 2026.

 

At the commencement of the Ivyland Lease, right-of-use assets obtained in exchange for new operating lease liabilities amounted to $115,037. The Ivyland Lease was terminated in April 2026.

 

Operating lease expense was $32,131 for the nine months ended September 30, 2026. Operating cash flows used for the operating leases during the nine months ended September 30, 2026, were $32,062. As of September 30, 2026, the weighted average remaining lease term was 0.83 years, and the weighted average discount rate was 12%.

 

Future minimum lease payments under non-cancellable leases as of September 30, 2026, were as follows:

 

      
Remainder of 2026  $4,840 
2027   7,260 
Total   12,100 
Less: Interest   (525)
Present value of lease liability   11,575 
Operating lease liability, current [1]   (11,575)
Operating lease liability, long term  $- 

 

 

[1] Represents lease payments to be made in the next 12 months.

 

NOTE 9 – STOCKHOLDERS’ EQUITY (DEFICIT)

 

Preferred Stock

 

We are authorized to issue up to 50,000,000 shares of preferred stock with a par value of $0.001 and our Board of Directors has the authority to issue one or more classes of preferred stock with rights senior to those of common stock and to determine the rights, privileges, and preferences of that preferred stock.

 

22

 

 

Our Board of Directors approved the designation of 2,000,000 of the Company’s shares of preferred stock as Series B Cumulative Redeemable Perpetual Preferred Stock (“Series B Preferred Stock”), each with a stated value of $25 per share. Holders of our Series B Preferred Stock are entitled to receive cumulative dividends at the annual rate of 13% per annum of the stated value, equal to $3.25 per annum per share. The Series B Preferred Stock is redeemable at our option or upon certain change of control events.

 

As of September 30, 2026, and December 31, 2025, we had 252,192 shares of preferred stock issued and outstanding.

 

Preferred Stock Dividends

 

During the nine months ended September 30, 2026, we declared $614,505 of cumulative cash dividends due to the holders of our Series B Preferred Stock. We made payments of $487,853 in cash and issued $134,535 worth of digital assets to reduce the amounts owing. As of September 30, 2026 and December 31, 2025, the dividend liability on our balance sheets was $231,893 and $239,776, respectively.

 

During the nine months ended September 30, 2025, we declared $614,505 for cumulative cash dividends due to the shareholders of our Series B Preferred Stock. We made payments of $499,275 in cash and issued $121,200 worth of digital assets to reduce the amounts owing.

 

Common Stock Transactions

 

On March 6, 2025, the Board of Directors authorized a stock repurchase program that will allow the Company to repurchase up to $1,000,000 in aggregate value of shares of the Company’s common stock, through March 31, 2026. The stock repurchase program was extended to cover the continued repurchase of shares of the Company’s common stock through March 31, 2027. During the nine months ended September 30, 2026, 4,821,883 shares were repurchased for $105,713. During the nine months ended September 30, 2025, 8,501,503 shares were repurchased for $137,261. These shares are temporarily being held by the Company in Treasury.

 

As of September 30, 2026 and December 31, 2025, we had 1,860,376,075 and 1,860,376,075 shares of common stock issued and 1,843,064,482 and 1,847,886,365 shares of common stock outstanding, respectively.

 

Options

 

The Investview, Inc. 2022 Incentive Plan authorizes a variety of incentive equity awards consisting of stock options, restricted stock, restricted stock units, and reserves for issuance up to 600,000,000 shares of the Company’s common stock.

 

During the nine months ended September 30, 2026, in connection with his appointment to the Board, Robert Verdun was granted an option to purchase 25,000,000 shares of the Company’s common stock at an exercise price of $0.05 under the Investview, Inc. 2022 Incentive Plan. 5,000,000 shares vest on each of February 5, 2027, February 5, 2028, February 5, 2029, February 5, 2030, and February 5, 2031, and in each case so long as he is a director or covered person of the Company as of such date. Additionally, in June 2026, the Company cancelled 49,625,000 unvested stock options upon forfeiture of such options by certain directors and executive officers of the Company’s management team. The Company also cancelled 5,200,000 unvested stock options upon the termination of employees of the Company. 

 

Transactions involving our options are summarized as follows:

 

           Weighted 
           Average 
       Weighted   Grant-Date 
   Number of   Average   Per Share 
   Options   Exercise Price   Fair Value 
Options outstanding at December 31, 2025   350,616,665   $0.05   $0.03 
Granted   25,000,000   $0.05   $0.03 
Canceled/Expired   (54,825,000)  $0.05   $0.03 
Exercised   -   $-   $- 
Options outstanding at September 30, 2026   320,791,665   $0.05   $0.03 

 

23

 

 

Details of our options outstanding as of September 30, 2026, are as follows:

 

Options Exercisable   Weighted Average Exercise Price of Options Exercisable   Weighted Average Contractual Life of Options Exercisable (Years)   Weighted Average Contractual Life of Options Outstanding (Years) 
 289,791,665    0.05    2.77    3.08 

 

Total stock compensation expense related to the options for the nine months ended September 30, 2026, and 2025, was $283,589 and $1,164,355, respectively. As of September 30, 2026, there was approximately $616,000 of unrecognized compensation cost related to the Options, which is expected to be recognized over a remaining weighted-average vesting period of approximately 2.3 years.

 

Warrants

 

Transactions involving our warrants are summarized as follows:

 

       Weighted 
   Number of   Average 
   Shares   Exercise Price 
Warrants outstanding at December 31, 2025   914,640   $0.10 
Granted   -   $- 
Canceled/Expired   (914,640)  $0.10 
Exercised   -   $- 
Warrants outstanding at September 30, 2026   -   $- 

 

Class B Units of Investview Financial Group Holdings, LLC

 

As of September 30, 2026, and December 31, 2025, there were 563,855,711 Class B Redeemable Units of our subsidiary, Investview Financial Group Holdings, LLC, issued and outstanding. These Class B Units were issued as consideration for the purchase of operating assets and intellectual property rights of MPower, a company controlled and partially owned by David B. Rothrock and James R. Bell, two of our board members. The Class B Units have no voting rights and were subject to a lock-up agreement that expired in April 2025. The outstanding Class B Units can be exchanged by the holders at any time for 563,855,711 shares of our common stock on a one-for-one basis, subject to the Company’s overriding right to redeem the Class B Units on the 7th anniversary of the date of issuance (September 3, 2028) or earlier if there are less than 50% of the Class B Units originally issued still outstanding or if the holders of a majority of the Class B Units request the mandatory redemption of all Class B Units. The Company has agreed to use its reasonable commercial efforts to register the resale of the common stock that may be issued upon redemption of the Class B Units under the Securities Act.

 

During the year ended December 31, 2025, we issued 1,144,289 shares of the Company’s common stock in exchange for the redemption of 1,144,289 Class B Units of Investview Financial Group Holdings, LLC.

 

NOTE 10 – COMMITMENTS AND CONTINGENCIES 

 

Litigation

 

Settlement of SEC Inquiry

 

In the ordinary course of business, we may be, or have been, involved in legal proceedings. On November 9, 2021, the Company received a subpoena from the United States Securities and Exchange Commission (“SEC”) for the production of documents. In the subpoena, the SEC advised that the inquiry did not mean that the SEC concluded that the Company or anyone affiliated with the Company had violated the federal securities laws or any other law. However, in the course of communications with the SEC throughout the inquiry, the Company came to believe that the focus of the SEC’s inquiry involved whether the offer and sale of the Company’s now-discontinued Apex sale and leaseback program violated certain federal securities laws. Following a several-year review process in which the Company cooperated fully with the SEC, on January 17, 2025, a settlement was reached with the SEC to resolve the inquiry. As part of the settlement, the Company entered into a formal SEC Order for which it neither admitted nor denied the factual and legal conclusions asserted; however, it agreed to pay a civil monetary penalty of $375,000 to conclude the inquiry. This penalty was expensed during the year ended December 31, 2024 and paid in January 2025. The Company considers this matter to be closed.

 

24

 

 

Exposure to potential claims arising from third-party financial protection plan

 

Historically, through our wholly-owned subsidiaries Apex Tek, LLC and SAFETek, LLC, we sold high-powered data processing equipment, known as the Apex package, to our customers which was then leased back to us for use in our crypto mining operations. We discontinued sales of the Apex package in June 2020, principally when COVID-19 created certain supply chain-related limitations on that business. Confronted with these limitations in the business, we offered the holders of our Apex leases the opportunity to cancel their leases, in exchange for which, we repurchased substantially all of the data processing equipment (subject to these leases) for approximately $19 million of promissory notes due on or about December 31, 2024 (which amount reflects the principal amount invested by all of such lease holders, plus a 25% premium). During the fourth quarter ended December 31, 2023, we further offered all note holders an early payoff option. By December 31, 2024, we had repaid or settled approximately $19 million of promissory notes.

 

Included in the Apex sale and leaseback program that was discontinued in 2021, was a “guaranteed assets buy-back product” underwritten, administered, managed and purportedly reinsured by a third-party provider, Total Protection Plus (“TPP”), which was intended to provide customers who participated in the Apex sale and leaseback program with a financial protection program (the “TPP Program”), under which customers, provided they complied with certain TPP required claims procedures, could elect to collect a cash payout in either a five-or-ten year interval after their initial purchase. As part of their sales and marketing materials, TPP represented that they were a purported affiliate of a well-known global insurance brokerage firm, and that through existing resources and reinsurance arrangements that were in place, they and their reinsurer had sufficient capital resources, reserves and liquidity to support any payouts needed to satisfy their obligations under the TPP Program. TPP was paid substantial premiums for the program. In most instances, the premium for the TPP program was included in the package price for the Apex program, at no additional cost to the customer.

 

Separately, other customers of ours who purchased ndau from the Company through an Oneiro sponsored ndau distribution program, were also given the opportunity to participate in a TPP Program similar to the program offered to our Apex customers; which in this case, was intended to provide customers who purchased ndau with a financial protection program under which such customers, provided they complied with certain TPP required claims procedures, could elect to collect a cash payout in either a five- or ten-year interval after their initial purchase. Participation in this program was also in reliance on sales and marketing materials by which TPP represented that they were a purported affiliate of a well-known global insurance brokerage firm, and that through existing resources and reinsurance arrangements that were in place, they and their reinsurer had sufficient capital resources, reserves and liquidity to support any pay-outs needed to satisfy their obligations under the TPP Program. Prior to terminating the distribution of ndau during August 2023, we distributed over $16.6 million in ndau to our customers in our belief that such purchases were supported by the TPP Program. As had been done with respect to the Apex customers, TPP was paid substantial premiums for the program, with those premiums included in the purchase price for the ndau program, at no additional cost to the customer.

 

During the fourth calendar quarter of 2021, we suspended any further offering of the TPP Program in connection with the sale of ndau after TPP was unable to comply with our vendor compliance protocols, having cited certain offshore confidentiality entitlements by which it was unwilling to provide evidence of its financial support arrangements. That suspension has remained in place as we have been unable to further validate the continued integrity of the TPP Program and the vendor’s ability to honor its commitments to our customers; despite the payment of over $6 million to TPP to secure the benefits of the TPP Program. Our level of concern over the viability of the TPP Program increased materially when in 2025 we came to learn that: (i) certain of our customers had been unable to reach TPP in order to process claims for their 5-year promised returns; (ii) the TPP website had been inoperative and customers had been unable to process their claims; and (iii) an email communication purportedly from TPP, or an affiliate thereof, had been received by certain customers in which the sender asserts that the obligations of TPP under the TPP Program were (unbeknownst to us and our customers) purportedly dependent on the financial wherewithal of another heretofore undisclosed TPP affiliate, that the email claims now had no ability to satisfy the commitments originally made by TPP. Our concern over the viability of the TPP program has recently been further validated as we have received information in connection with our litigation efforts (as discussed below) that suggests that the TPP Program was dependent upon reinsurance commitments, which were, in turn, dependent upon the reinsurer’s receipt of certain annual installment payments from TPP, who purportedly failed to make these installment payments. Even though our investigation of the matter has not concluded, these preliminary findings appear to support our concerns over the viability of the TPP Program.

 

25

 

 

To respond to these concerns, and in part, in an effort to advance the interests of our customers, on March 28, 2025, we commenced an action in equity against Total Protection Plus, UIU Holdings LLC, Jason R. Anderson, Jacob S. Anderson, and Schad E. Brannon (collectively, “TPP”), in the Court of Chancery of the State of Delaware captioned Investview et al., v. UIU Holdings, LLC et al., seeking to, among other things, compel TPP to fulfill the commitments that were made to the Company’s customers under the TPP Program. In response, the Defendants filed various motions to dismiss, making both procedural and substantive challenges to the allegations made in the Complaint. The Company opposed those motions, and after a hearing before the Chancery Court, in a letter opinion dated November 21, 2025, the Chancery Court (which is a court of equity) ruled that it lacked subject matter jurisdiction over the Company’s claims because, among others: (i) it is a court of equity and the claims asserted by the Company were not purely equitable in nature; and (ii) a suit for money damages would provide the Company an adequate remedy at law. The Court dismissed the Complaint on these procedural grounds with leave to transfer the case to Delaware Superior Court, which does not have the same limited jurisdiction that exists in Chancery Court. At no point did the Chancery Court address or rule on the substance of our claims against TPP.

 

In response to the dismissal of the case, in January 2026, we renewed our case against TPP by transferring the case to Delaware Superior Court, and then filing an Amended Complaint in Superior Court, including additional factual allegations to support our claims. In the Amended Complaint, the Company removed Schad Brannon as one of the Defendants, and is now pursuing relief against UIU Holdings LLC d/b/a Total Protection Plus, Jason R. Anderson, and Jacob S. Anderson. The Defendants responded to the Amended Complaint in February 2026 by filing motions to dismiss along similar grounds as to what they argued in Chancery Court, including arguments that the Court lacks personal jurisdiction over Jacob Anderson, the Company lacks standing to pursue its claims, and the claims otherwise fail as a matter of law. The Company responded to the motions to dismiss and the Court heard oral argument on the motions in June 2026. The court took the matter under advisement and has not yet issued a ruling on the motions to dismiss. To date, the court process has not yet addressed the substance of our claim. Due to the uncertainties and procedural delays associated with matters of litigation, and in recognition of the early-stage of the proceedings, we cannot assure that the outcome of the legal proceedings will be consistent with our objectives.

 

Despite our efforts in court, we cannot ensure that TPP will comply with its contractual commitments to our customers, in which case these customers may not be able to realize the cash payouts promised by TPP; despite the substantial payments made to TPP to secure the promised benefits of the TPP Program. As the direct responsibility for compliance with the TPP Program resides with TPP; particularly as the program was underwritten, managed, administered, and purportedly reinsured by TPP as an independent third-party vendor (and with respect to ndau, the underlying ndau was developed and marketed by an additional third-party vendor), and in recognition of the customers’ acceptance of their participation in the program, we do not believe that we have any legal responsibility to cover any potential claims of customers who participated in the TPP Program. There is, however, a risk that any failure of TPP to perform its obligations to our customers could expose us to commercial claims of dissatisfied customers, regardless of the legal foundation associated therewith. The possible assertion of those claims, regardless of the underlying substance of the claims, could have an adverse effect on our business, financial condition, and operating results.

 

26

 

 

Exposure to a substantial fine and a cease-and-desist order issued by the Polish Office of Competition and Consumer Protection (“UOKiK”) finding that the Company’s direct to consumer marketing business violated Polish laws that prohibit pyramid-style promotional schemes.

 

In December 2025, UOKiK issued a formal administrative decision concluding its investigation of the operations of the Company’s direct to consumer marketing business in Poland. In its decision, UOKiK determined that certain aspects of our direct selling business model, as conducted in Poland, violate Polish laws relating to unfair commercial practices, including laws prohibiting pyramid-style promotional schemes. The decision imposes an administrative fine of PLN 14,668,589 (approximately USD $4 million) and includes an order requiring the Company to cease and desist the practices described in the decision. Under the terms of the decision, enforcement of the fine and cease and desist components thereof, is not final and is subject to the conclusion of any appeal to the competent Polish court.

 

The Company does not agree with the conclusions set forth in the decision based upon its interpretation of Polish law as applied to the manner in which it sells its products and services in Poland and intends to avail itself of all procedural rights of appeal and legal remedies available under applicable law. In February 2026, the Company timely filed an appeal of UOKiK’s administrative decision with Poland’s Court of Competition and Consumer Protection. That appeal is pending. The Polish appeals court originally set a hearing date of September 1, 2026, to conduct a hearing on the appeal, but that date was rescheduled and we are awaiting a new hearing date. During the appeal process, the Company expects to continue operations in Poland in the normal course, while evaluating such operational adjustments as may be appropriate to further demonstrate that its operations in Poland do not constitute an unlawful pyramid scheme. While we intend to vigorously defend ourselves against the UOKiK decision, if we are ultimately unsuccessful in our defense of the matter on appeal, we could, among other things, be subject to the administrative fine imposed and may be required to modify, suspend or discontinue certain aspects of our direct selling operations or a material portion of our operations in Poland, which such outcome could have an adverse effect on the Company’s business, financial condition, results of operations, or prospects. Nevertheless, a loss contingency of approximately $3.81 million was accrued as of September 30, 2026. This loss is presented within “Accrued liabilities, long term” in our consolidated balance sheet. Although we are not aware of any other claims, there is a possible risk that we could become exposed to similar inquiries or proceedings from other regulators in the European Union or the United States. If this were to occur, we could be exposed to further fines or decisions that could have a similar adverse impact on our operations in Europe or the United States. We believe this risk is largely responsible for the material contraction in the European sales of our direct to consumer business unit since the December 2025 formal administrative decision issued by UOKiK, particularly given that the majority of the revenues derived from our direct to consumer business unit prior to December 2025 were derived from customers in the European Union.

 

Outstanding commitments associated with termination of former Chief Executive Officer

 

Joseph Cammarata served as an officer and director of the Company from December 2019 through his termination for cause on or about December 7, 2021. Mr. Cammarata was terminated following the announcement of civil and criminal charges filed against him in connection with his involvement with a class action claims aggregator unrelated to the Company. The Company was unaware of these outside business interests. Based on public reporting of the matter, the Company believes that Mr. Cammarata was convicted of certain of these criminal charges and is presently incarcerated.

 

Prior to his termination, the Company issued a promissory note to Mr. Cammarata, which, following certain modifications, on or about March 30, 2021, was restated in the principal amount of $1,550,000 (the “Cammarata Note”). Although not originally convertible, as per the March 30, 2021, amendment, the Cammarata Note became convertible at $0.02 per share. Thereafter, effective September 21, 2021, and following another modification, the conversion price under the Cammarata Note was reduced to $0.008 per share. During February 2022, we provided 30 days’ notice of our intent to retire and repay the Cammarata Note in cash. Having not timely received a properly executed conversion notice within the prescribed period and citing certain breaches of Mr. Cammarata’s fiduciary duty to us, as well as damages incurred by us arising from Mr. Cammarata’s then ongoing legal proceedings, on or about March 31, 2022, we tendered to Mr. Cammarata cash payment in full for the Cammarata Note. As of the date of this Report, Mr. Cammarata has not accepted our tender of the cash payment, and through his then counsel, has asserted his entitlement to exercise his right to convert the Cammarata Note into our common shares. Although we believe that our cash tender was appropriate under the terms of the Cammarata Note and our claims for damages against Mr. Cammarata have merit, if Mr. Cammarata elects to challenge our cash tender in a court proceeding, and if we are unable to sustain our legal position on the matter, Mr. Cammarata could receive up to approximately 203 million shares of our common stock upon conversion of the Cammarata Note. As a result of his incarceration, the Company has been unable to further adjudicate these issues with Mr. Cammarata.

 

27

 

 

Further, on March 22, 2021, we entered into Securities Purchase Agreements to purchase 100% of the operating assets of SSA Technologies LLC, an entity that owns and operates a FINRA-registered broker-dealer. SSA is controlled and partially owned by Joseph Cammarata, our former Chief Executive Officer. Commencing upon execution of the agreements and through the closing of the transactions, we agreed to provide certain transition service arrangements to SSA. In connection with the transactions, we entered into a Working Capital Promissory Note with SSA under which SSA was to have advanced to us up to $1,500,000 before the end of 2021; however, SSA has only provided advances of $1,200,000 to date. The note bears interest at the rate of 0.11% per annum therefore we recognized $990 worth of interest expense on the loan during the nine months ended September 30, 2026. The note was due and payable by January 31, 2022; however, it has not yet been repaid as we consider our legal options in light of SSA’s failure to complete its funding obligations. The note was to have been secured by the pledge of 12,000,000 shares of our common stock; however, it remains unsecured as the pledge of shares was not implemented at the closing of the loan. As a result of his incarceration, the Company has been unable to further adjudicate these issues with Mr. Cammarata.

 

NOTE 11 – SEGMENT REPORTING

 

The Company has two reportable segments, Direct-to-Consumer Marketing Platform and Manufacturing and Development of Health, Beauty, and Wellness Products. The reportable segments are identified based on the types of products and services that generate revenue.

 

The Company is also developing a start-up business unit that is intended to operate within the Brokerage and Financial Technologies Services sector once and to the extent it can commence operations.

 

The segment performance that the CODM uses to measure performance is net income (loss) from operations. The Company does not allocate assets to the reporting segments as its assets are primarily managed on an entity-wide basis and therefore does not disclose the total assets of its reportable operating segments.

 

For the nine months ended September 30, 2026, and 2025, all intersegment revenues and costs of revenues were eliminated in the Consolidated Statements of Operations.

 

The Direct-to-Consumer Marketing Platform segment generates revenue through membership fees and the sale of products. The Manufacturing and Development of Health, Beauty, and Wellness Products generates revenue primarily through the sale of health, beauty, and wellness products manufactured and sold to wholesale and retail customers.

 

The following table illustrates segment revenue and segment net income from operations, including significant expense items reviewed by the CODM for the three months ended September 30, 2026.

 

   Direct-to-Consumer Marketing Platform   Manufacturing and Development of Health, Beauty, and Wellness Products   Total 
Revenue  $2,088,351   $150,229    2,238,580 
                
Less:               
Commissions   1,227,322    1,825    1,229,147 
Market experts   130,600    -    130,600 
Credit card processing   81,907    -    81,907 
Salary and related   432,774    386,519    819,293 
Depreciation   255    -    255 
Cost of sales   74,829    131,383    206,212 
General and administrative [1]   679,015    183,591    862,606 
                
Segment net income (loss) from operations  $(538,351)  $(553,089)  $(1,091,440)

 

 

[1] General and administrative costs consist mainly of professional fees, contracting services, insurance, information technology and software, and other payment processing fees.

 

28

 

 

The following table illustrates segment revenue and segment net income from operations, including significant expense items reviewed by the CODM for the three months ended September 30, 2025.

 

   Direct-to-Consumer Marketing Platform   Manufacturing and Development of Health, Beauty, and Wellness Products   Total 
Revenue  $7,066,734   $1,062,271   $8,129,005 
                
Less:               
Commissions   4,008,062    -    4,008,062 
Market experts   181,256    -    181,256 
Credit card processing   316,779    -    316,779 
Salary and related   399,655    416,690    816,345 
Depreciation   431    -    431 
Cost of sales   -    920,048    920,048 
General and administrative [1]   897,446    355,515    1,252,961 
                
Segment net income (loss) from operations  $1,263,105   $(629,982)  $633,123 

 

 

[1] General and administrative costs consist mainly of professional fees, contracting services, insurance, information technology and software, and other payment processing fees.

 

The following table illustrates the reconciliation of segment operating income to net income (loss) from continuing operations before income taxes for the three months ended September 30, 2026 and 2025.

 

   September 30, 2026   September 30, 2025 
Segment income (loss) from operations  $(1,091,440)  $633,123 
           
Reconciling items          
Other profit (loss) [1]   10,129,143    (1,696,022)
Bank interest   -    53,859 
Event ticket sales   -    221,757 
All other, net   595    222,550 
           
Net income (loss) from continuing operations before income taxes  $9,038,298   $(564,733)

 

 

[1] Other profit (loss) is attributable to corporate and nonoperating segment expenses and is therefore not included in the segment income (loss) from operations.

 

29

 

 

The following table illustrates segment revenue and segment net income from operations, including significant expense items reviewed by the CODM for the nine months ended September 30, 2026.

 

   Direct-to-Consumer Marketing Platform   Manufacturing and Development of Health, Beauty, and Wellness Products   Total 
Revenue  $7,402,345    652,638    8,054,983 
                
Less:               
Commissions   4,220,876    5,259    4,226,135 
Market experts   434,076    -    434,076 
Credit card processing   283,996    -    283,996 
Salary and related   1,304,557    1,216,229    2,520,786 
Depreciation   859    -    859 
Cost of sales   182,100    532,403    714,503 
General and administrative [1]   2,099,966    534,389    2,634,355 
                
Segment net income (loss) from operations  $(1,124,085)   (1,635,642)   (2,759,727)

 

 

 

[1] General and administrative costs consist mainly of professional fees, contracting services, insurance, information technology and software, and other payment processing fees.

 

The following table illustrates segment revenue and segment net income from operations, including significant expense items reviewed by the CODM for the nine months ended September 30, 2025.

 

   Direct-to-Consumer Marketing Platform   Manufacturing and Development of Health, Beauty, and Wellness Products   Total 
Revenue  $23,702,859    2,787,941    26,490,800 
                
Less:               
Commissions   13,260,667    -    13,260,667 
Market experts   542,376    -    542,376 
Credit card processing   1,042,958    -    1,042,958 
Salary and related   1,240,463    1,093,898    2,334,361 
Depreciation   1,336    -    1,336 
Cost of sales   -    2,474,715    2,474,715 
General and administrative [1]   2,045,147    916,846    2,961,993 
                
Segment net income (loss) from operations  $5,569,912    (1,697,518)   3,872,394 

 

 

[1] General and administrative costs consist mainly of professional fees, contracting services, insurance, information technology and software, and other payment processing fees.

 

30

 

 

The following table illustrates the reconciliation of segment operating income to net income (loss) from continuing operations before income taxes for the nine months ended September 30, 2026 and 2025.

 

   September 30, 2026   September 30, 2025 
Segment income (loss) from operations  $(2,759,727)  $3,872,394 
           
Reconciling items          
Other profit (loss) [1]   5,345,471    (4,384,585)
Event ticket sales   -    154,394 
Bank interest   57,922    274,430 
All other, net   19,297    222,368 
           
Net income (loss) from continuing operations before income taxes  $2,662,963   $139,001 

 

 

[1] Other profit (loss) is attributable to corporate and nonoperating segment expenses and is therefore not included in segment income (loss) from operations.

 

NOTE 12 – EQUITY INVESTMENT

 

Our Equity investment of $3.3 million did not have a readily determinable fair value and consisted of non-marketable equity securities, which were investments in a special purpose vehicle organized by Dream Ventures LLC, which participated in an exempt private placement in an early-stage enterprise developing next-generation nuclear power and infrastructure technologies. The Company’s investment consisted of the acquisition of restricted units of the SPV, which, in turn, used the proceeds to invest in private investment securities of the early-stage nuclear enterprise. The Company is not in the business of making investments in private securities, however, this investment was viewed by the Board of Directors as a strategic investment intended to access a possible growth opportunity that takes advantage of renewed momentum around modular, rapidly deployable energy systems, supported by recent federal initiatives and Department of Energy programs promoting advanced-reactor innovation. We did not possess a controlling financial interest or exercise significant influence over the SPV, and any proposed transfers of units required prior written consent of the SPV.

 

During the nine months ended September 30, 2026, we sold our $3.3 million investment for $12.8 million and recognized a $9.6 million gain. As of September 30, 2026 and December 31, 2025, our investment in the SPV was $0 and $1.3 million, respectively.

 

NOTE 13 – DISCONTINUED OPERATIONS

 

On July 8, 2026, the Company discontinued operations of its subsidiary SAFETek, LLC.

 

In accordance with the provisions of ASC 205-20, the assets and liabilities have been reflected as discontinued operations in the condensed consolidated balance sheets as of September 30, 2026 and December 31, 2025, and consist of the following:

 

   September 30, 2026   December 31, 2025 
Current assets of discontinued operations:          
Deposits, current  $37,320   $936,434 
Receivables   3,075    13,194 
Total current assets of discontinued operations  $40,395   $949,628 
           
Total fixed assets, net of discontinued operations [1]  $-   $118,257 
           
Other assets of discontinued operations:          
Deposits  $-   $37,320 
Total other assets of discontinued operations  $-   $37,320 
           
Current liabilities of discontinued operations:          
Accounts payable and accrued liabilities  $135   $14,029 
Payroll liabilities   3,514    1,825 
Total current liabilities of discontinued operations  $3,649   $15,854 

 

[1] Fixed assets of discontinued operations were made up of the following at each balance sheet date:

 

31

 

 

In accordance with the provisions of ASC 205-20, the results of operations of the discontinued operations for the three and nine months ended September 30, 2026 and 2025 have been reflected as discontinued operations in the condensed consolidated statements of operations, and consist of the following:

 

   2026   2025   2026   2025 
   Three Months Ended September 30,   Nine Months Ended September 30, 
   2026   2025   2026   2025 
                 
Revenue of discontinued operations:                    
Mining revenue [2]  $41,092   $923,603   $1,153,163   $2,615,778 
Total revenue, net of discontinued operations   41,092    923,603    1,153,163    2,615,778 
                     
Operating costs and expenses of discontinued operations:                    
Cost of sales and service [3]   -    1,052,220    1,690,321    3,143,119 
Advertising, selling, and marketing   -    -    51    - 
Salary and related   31,831    56,256    129,715    272,277 
Loss (gain) on disposal of assets [1]   (12,878)   (21,414)   (25,652)   (113,251)
General and administrative   9,745    187,415    202,444    743,305 
Total operating costs and expenses of discontinued operations   28,698    1,274,477    1,996,879    4,045,450 
                     
Operating net income (loss) of discontinued operations   12,394    (350,874)   (843,716)   (1,429,672)
                     
Other income (expense) of discontinued operations:                    
                     
Other income (expense)   1,038    63,244    131,527    189,733 
Total other income (expense) of discontinued operations   1,038    63,244    131,527    189,733 
                     
Income (loss) before income taxes of discontinued operations   13,432    (287,630)   (712,189)   (1,239,939)
Income tax benefit (expense)   101,326    -    101,326    - 
Net income (loss) of discontinued operations  $114,758   $(287,630)  $(610,863)  $(1,239,939)

 

32

 

 

[1] Fixed assets of discontinued operations were made up of the following at each balance sheet date:
Revenue Recognition

[3] Cost of Sales and Service

 

[1] Fixed assets of discontinued operations were made up of the following at each balance sheet date:

 

   Estimated        
   Useful        
   Life  September 30,   December 31, 
   (years)  2026   2025 
Computer equipment  3  $     -   $4,826 
Data processing equipment  3   -    7,381,111 
Gross book value      -    7,385,937 
Accumulated depreciation      -    (7,267,680)
Net book value     $-   $118,257 

 

Total depreciation expense for the nine months ended September 30, 2026 and 2025, was $110,531 and $477,303, respectively. During the nine months ended September 30, 2026, we sold assets with a total net book value of $0 for cash of $9,858 and digital assets worth $23,520 and disposed of assets with a net book value of $7,726, therefore recognized a net gain on disposal of assets of $25,652. During the nine months ended September 30, 2025, we sold assets with a total net book value of $31,227 for digital assets worth $144,478, therefore recognized a gain on disposal of assets of $113,251.

 

[2] Revenue Recognition

 

Mining Revenue

 

Through the first week of July 2026, we generated revenue from mining bitcoin. Subsequently, we discontinued our bitcoin mining business. The Company entered into a digital asset mining pool by executing a contract, as amended from time to time, with the mining pool operator to provide computing power to the mining pool. The contract was terminable at any time by either party without penalty. Further, since the contract was continuously renewing, second by second, the mining contract was considered to have a duration of less than 24 hours for accounting purposes. The Company’s enforceable right to compensation only began when the Company provided computing power to the mining pool operator. In exchange for providing computing power, we were entitled to a Full-Pay-Per-Share payout of Bitcoin based on a contractual formula, which calculated our share of block rewards, transaction fees, and mining pool operator fees. We were entitled to consideration even if a block was not successfully placed by the mining pool operator.

 

Providing computing power to solve complex cryptographic algorithms in support of the Bitcoin blockchain (in a process known as “solving a block”) was an output of the Company’s ordinary activities. The provision of providing such computing power was the only performance obligation in the Company’s contract with the mining pool operator. The transaction consideration the Company received was net of a contractually agreed-upon mining pool operator fee charged and kept by the mining pool operator and was noncash, in the form of Bitcoin. Given that the contract was continuously renewing, and the duration is considered to be less than 24 hours, the Company measured the transaction consideration at fair value on the date Bitcoin was received. The consideration was variable. The amount of consideration recognized was constrained to the amount of consideration received, which was when it was probable a significant reversal would not occur. There was no significant financing component or risk of a significant revenue reversal in these transactions due to the performance obligations and settlement of the transactions being on a daily basis.

 

[3] Cost of Sales and Service

 

Included in our costs of sales and services are hosting and electricity fees that we pay to vendors to set up our mining equipment at third-party sites in order to generate mining revenue.

 

In accordance with the provisions of ASC 205-20, the cash flow activity from discontinued operations for the nine months ended September 30, 2026 and 2025 have been reflected as discontinued operations in the condensed consolidated statements of cash flows, and consists of the following:

 

   2026   2025 
   Nine Months Ended September 30, 
   2026   2025 
CASH FLOWS FROM DISCONTINUED OPERATING ACTIVITIES:          
Net income (loss)  $(610,863)  $(1,239,939)
Depreciation   110,531    477,303 
(Gain) loss on disposal of assets   (25,652)   (113,251)
Revenue recognized from bitcoin mined   (1,152,156)   (2,615,778)
Operating expenses paid with digital assets   27,246    53,384 
Receivables   10,119    (5,060)
Prepaid assets   -    8,131 
Deposits   936,434    - 
Accounts payable and accrued liabilities   (12,205)   (30,461)
Net cash provided by (used in) operating activities - discontinuing  $(716,546)  $(3,465,671)
           
CASH FLOWS FROM DISCONTINUED INVESTING ACTIVITIES:          
Proceeds from sale of fixed assets  $9,858   $- 
Net cash provided by (used in) investing activities - discontinuing  $9,858   $- 

 

NOTE 14 – INCOME TAXES

 

For the periods ended September 30, 2026, and September 30, 2025, the Company used a discrete effective tax rate method for recording income taxes, as compared to an estimated full-year annual effective tax rate method, as an estimate of the annual effective tax rate cannot be made.

 

Provision for Income taxes from continuing operations for the three and nine months ended September 30, 2026 was $160,104 and $162,657 resulting in an effective tax rate of 1.8% and 6.1%. Provision for Income taxes for the three and nine months ended September 30, 2025 was $ 0 and $11,000, resulting in an effective tax rate of (0)% and (7.9)%. The provision for income taxes was primarily impacted by pretax book income, permanent differences, and by the change in valuation allowance on deferred tax assets.

 

NOTE 15 – SUBSEQUENT EVENTS

 

In accordance with ASC Topic 855, Subsequent Events, we have evaluated subsequent events through the date of this filing and have determined that the following events require disclosure.

 

During the period subsequent to quarter end, according to the stock repurchase program (see NOTE 9), the Company bought back 645,097 shares of its own common stock for $10,024. These shares are being held by the Company in Treasury.  

 

33

 

 

ITEM 2 – MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Forward-Looking Statements

 

All statements in this Report that are not based on historical fact are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies, and expectations, can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may,” “should,” “could,” “seek,” “intend,” “plan,” “goal,” “estimate,” “anticipate” or other comparable terms. These forward-looking statements are based on management’s current beliefs and assumptions and information currently available to management and involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company to be materially different from any future results, performance, or achievements expressed or implied by these forward-looking statements. Our forward-looking statements expect that we will be able to expand the scope and scale of our Conectiv network, despite the reductions in revenue experienced by this business segment during 2025, and followed by the more significant contraction in the business that occurred during the first three quarters of 2026. These expectations assume that our Q1 2026 onboarding of certain other direct selling networks will result in material additional sales growth, even though no such sales growth was experienced during Q2 or Q3 of 2026, nor can such sales growth be assured as these other direct selling networks that we onboarded consist solely of independent distributors who are not contractually or otherwise required to sell any Conectiv products or services. Growth is also expected from our Manufacturing and Development of Health, Beauty and Wellness Products Segment, as we continue to seek out and onboard additional products for sale, even though we have over time experienced reduction in sales of that business unit and have no customer or other sales commitments upon which to base that expectation. Our forward-looking statements also expect that we will ultimately be able to develop retail brokerage operations at Opencash, although we have previously forecasted the commencement of operations and that unit is still in the pre-revenue and early stage of its operations. We plan to do this by, among others, investing the funds we believe are necessary to develop the infrastructure necessary to achieve retail operations. This includes, among others, the onboarding of customer support personnel and software developers, the development and implementation of a marketing strategy, the securing of necessary securities clearing arrangements, and the continued development of the online Opencash trading platform and completing its integration with the proprietary algorithmic trading platform we acquired in September 2021. Despite our best efforts, there can be no assurance that we will be able to achieve these objectives on a timely basis, if at all, as the development of an early-stage securities brokerage business involves inherent regulatory and operational risks and uncertainties, including the uncertain ability of us to integrate the Opencash investment platform application with the proprietary algorithmic trading platform we acquired in September 2021, particularly as the platform we acquired in 2021 has not been placed in commercial service since 2021; thus, any such integration could be subject to IT-related and commercial risks. Furthermore, all of our forward-looking statements presume that we will be able to continue to operate as a going concern in the long-term. As noted in this Report, should our strategic initiatives fail to mitigate our losses from operations or otherwise achieve their targeted objectives, then in the absence of our ability to access additional debt or equity capital, our ability to sustain our operations in the long-term as a going concern may be subject to doubt. More information on potential factors that could affect our financial results is included from time to time in our public reports filed with the U.S. Securities and Exchange Commission, including the Company’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. The forward-looking statements made in this Report speak only as of the date of this Report, and we assume no obligation to update any such forward-looking statements to reflect actual results or changes in expectations, except as otherwise required by law.

 

Business Overview

 

We operate a diversified series of business units across key sectors, including a direct-to-consumer (“DTC”) marketing platform designed to promote, sell, and distribute its products and services through a global network of independent distributors directly to end users without reliance on traditional retail intermediaries; a manufacturing, marketing, and sales division focused on proprietary over-the-counter aesthetics, health, nutrition and cognitive wellness products for distribution across wholesale and retail markets through our DTC marketing platform and otherwise; and an early-stage online trading platform that intends to offer self-directed retail brokerage services. A bitcoin mining business that we previously operated through the first week of July 2026 has been terminated and those operations have been discontinued.

 

Results of Operations

 

Three Months Ended September 30, 2026 Compared to Three Months Ended September 30, 2025

 

Revenues

 

   Three Months Ended September 30,   Increase 
   2026   2025   (Decrease) 
   (unaudited)   (unaudited)     
Membership revenue, net of refunds, incentives, credits, and chargebacks  $1,819,488   $7,066,734   $(5,247,246)
Health and wellness product sales   238,372    1,029,673    (791,301)
Coffee sales   177,636    -    177,636 
Other revenue   3,084    32,598    (29,514)
Total revenue, net  $2,238,580   $8,129,005   $(5,890,425)

 

During the three months ended September 30, 2026, our financial results were adversely affected as we continued to experience significant headwinds across virtually all of our operating segments. Most significantly, the Membership revenue component of our DTC marketing platform experienced a year-over-year 74% reduction in quarterly revenue, from $7.1 million to $1.8 million, which we believe is directly attributable to a contraction of our European marketing network in response to the December 2025 formal administrative decision issued by UOKiK, Poland’s Office of Competition and Consumer Protection. Our Q3 2026 results were further impacted by a year-over-year 77% decrease in Health and wellness product sales, from $1.0 million to $0.2 million. Collectively, the decline in business segment revenue contributed to a consolidated net loss from operations of $2.1 million for the quarter, compared to net loss from operations of $0.7 million for the three months ended September 30, 2025.

 

34

 

 

In response to these trends, during Q4 2025 and Q1 2026, we announced a strategic transition of our direct-to-consumer business unit toward a more diversified operating platform which is expected to integrate our health and wellness and consumer products offerings, with our existing financial education products and services offerings. Also, during the fourth quarter of 2025 and the second quarter of 2026, we commenced the expansion of our direct-selling networks through the onboarding of two additional selling networks. Despite our expectations that these initiatives were expected to expand our global distributor network, diversify our revenue base, and supplement the network capacity and revenue streams, no such expansion or improvement in our operations has, thus far, occurred in 2026.

 

In addition, in response to the UOKiK decision, we continue to take active steps to address the findings, including appealing the decision and continuing our operations in Poland, as we remain committed to operating in Poland in full compliance with applicable laws. Based on our analysis of the applicable legal standards and our review of sales activity within Poland, in which the predominant portion of revenue is derived from membership sales driven by our members, we believe that the Conectiv direct selling business operating within Poland complies with all applicable legal standards, and we will continue to challenge the conclusions reached by UOKiK to the extent permitted within the Polish legal system. Until we are able, if at all, to secure a positive result in our ongoing litigation with UOKiK, we are likely to experience a continued contraction in our European marketing network.

 

Operating Costs and Expenses

 

   Three Months Ended September 30,   Increase 
   2026   2025   (Decrease) 
   (unaudited)   (unaudited)     
Cost of sales and service  $336,811   $1,101,304   $(764,493)
Commissions   1,229,147    4,008,062    (2,778,915)
Salary and related   1,380,535    1,717,067    (336,532)
Professional fees   286,646    534,687    (248,041)
General and administrative   1,067,365    1,454,817    (387,452)
Total operating costs and expenses  $4,300,504   $8,815,937   $(4,515,433)

 

Operating costs decreased $4,515,433 or (51%), from $8,815,937 for the three months ended September 30, 2025, to $4,300,504 for the three months ended September 30, 2026. The decrease can be explained by a reduction in commissions of $2.8 million, which was a result of a decrease in our membership revenue, a reduction in salary and related, which was a result of a decrease in stock-based compensation expense due to certain directors and executive officers of the Company’s management team forfeiting unvested stock options during Q2 2026, a decrease of $0.8 million in cost of sales and service due to decrease in membership revenue and health and wellness product sales, and a decrease in general and administrative expenses.

 

Other Income and Expenses

 

   Three Months Ended September 30,     
   2026   2025   Change 
   (unaudited)   (unaudited)     
Gain (loss) on settlement  $-   $(111,277)  $111,277 
Gain (loss) on investment   9,588,570    -    9,588,570 
Gain (loss) on fair value of derivative liability   -    (20)   20 
Realized gain (loss) on digital assets   (37,997)   (42,737)   4,740 
Unrealized gain (loss) on digital assets   1,717,496    219,771    1,497,725 
Interest expense   (5,620)   (4,726)   (894)
Interest expense, related parties   (310,594)   (310,594)   - 
Other income (expense)   148,367    371,782    (223,415)
Total other income (expense)  $11,100,222   $122,199   $10,978,023 

 

35

 

 

We recorded other income of $11,100,222 for the three months ended September 30, 2026, which was an increase of $10,978,023, or 8,984%, from the prior year’s other income of $122,199. The change is due to an increase in the gain on investment in the current period of $9.6 million compared to no gain in the prior year and an unrealized gain on digital assets in the current period of $1.7 million compared to a gain of $220 thousand in the prior year. The gain on investment in the current period is from the sale of our $3,250,000 investment in a special purpose vehicle organized by Dream Ventures LLC for $12,838,570.

 

Nine Months Ended September 30, 2026 Compared to Nine Months Ended September 30, 2025

 

Revenues

 

   Nine Months Ended September 30,   Increase 
   2026   2025   (Decrease) 
   (unaudited)   (unaudited)     
Membership revenue, net of refunds, incentives, credits, and chargebacks  $6,659,883   $23,702,859   $(17,042,976)
Health and wellness product sales   749,696    2,709,692    (1,959,996)
Coffee sales   630,141    -    630,141 
Other revenue   15,263    78,249    (62,986)
Total revenue, net  $8,054,983   $26,490,800   $(18,435,817)

 

During the nine months ended September 30, 2026, our financial results were adversely affected as we continued to experience significant headwinds across virtually all of our operating segments. Most significantly, the Membership revenue component of our DTC marketing platform experienced a year-over-year 72% reduction in revenue, from $23.7 million to $6.7 million, which we believe is directly attributable to a contraction of our European marketing network in response to the December 2025 formal administrative decision issued by UOKiK, Poland’s Office of Competition and Consumer Protection. Our 2026 results were further impacted by a year-over-year 72% decrease in Health and Wellness product sales, from $2.7 million to $0.7 million. Collectively, the decline in business segment revenue contributed to a consolidated net loss from operations of $6.4 million for first nine months of 2026, compared to net loss from operations of $38 thousand for the first nine months of 2025.

 

In response to these trends, during Q4 2025 and Q1 of 2026, we announced a strategic transition of our direct-to-consumer business unit toward a more diversified operating platform, which is expected to integrate our health and wellness and consumer products offerings, with our existing financial education products and services offerings. Also, during the fourth quarter of 2025 and subsequent to the close of the first quarter of 2026, we commenced the expansion of our direct-selling networks through the onboarding of two additional selling networks. Despite our expectations that these initiatives would offer the potential to expand our global distributor network, diversify our revenue base, and supplement the network capacity and revenue streams, no such expansion or improvement in our operations has, thus far, occurred in 2026.

 

In addition, in response to the UOKiK decision, we continue to take active steps to address the findings, including appealing the decision and continuing our operations in Poland, as we remain committed to operating in Poland in full compliance with applicable laws. Based on our analysis of the applicable legal standards and our review of sales activity within Poland, in which the predominant portion of revenue is derived from membership sales driven by our members, we believe that the Conectiv direct selling business operating within Poland complies with all applicable legal standards, and we will continue to challenge the conclusions reached by UOKiK to the extent permitted within the Polish legal system. Until we are able, if at all, to secure a positive result in our ongoing litigation with UOKiK, we are likely to continue to experience a continued contraction in our European marketing network.

 

36

 

 

Operating Costs and Expenses

 

   Nine Months Ended September 30,   Increase 
   2026   2025   (Decrease) 
   (unaudited)   (unaudited)     
Cost of sales and service  $1,148,580   $3,017,091   $(1,868,511)
Commissions   4,226,135    13,260,667    (9,034,532)
Salary and related   4,317,405    4,930,547    (613,142)
Professional fees   1,426,959    1,538,395    (111,436)
General and administrative   3,292,157    3,782,408    (490,251)
Total operating costs and expenses  $14,411,236   $26,529,108   $(12,117,872)

 

Operating costs decreased $12,117,872 or (46%), from $26,529,108 for the nine months ended September 30, 2025, to $14,411,236 for the nine months ended September 30, 2026. The decrease can be explained by a reduction in commissions of $9.0 million, which was a result of a decrease in our membership revenue, a reduction in salary and related, which was a result of a decrease in stock-based compensation expense due to certain directors and executive officers of the Company’s management team forfeiting unvested stock options, a decrease of $1.9 million in cost of sales and service due to decrease in membership revenue and health and wellness product sales, and decreases in professional fees and general and administrative expenses.

 

Other Income and Expenses

 

   Nine Months Ended September 30,     
   2026   2025   Change 
   (unaudited)   (unaudited)     
Gain (loss) on settlement  $-   $(111,277)  $111,277 
Gain (loss) on investment   9,588,570    -    9,588,570 
Gain (loss) on fair value of derivative liability   -    133    (133)
Realized gain (loss) on digital assets   (89,728)   77,006    (166,734)
Unrealized gain (loss) on digital assets   19,100    399,029    (379,929)
Interest expense   (14,918)   (16,682)   1,764 
Interest expense, related parties   (929,008)   (929,008)   - 
Other income (expense)   445,200    758,108    (312,908)
Total other income (expense)  $9,019,216   $177,309   $8,841,907 

 

We recorded other income of $9,019,216 for the nine months ended September 30, 2026, which was an increase of $8,841,907, or 4,987%, from the prior year’s other income of $177,309. The change is due to an increase in the gain on investment in the current period of $9.6 million compared to no gain in the prior year and no loss on settlement in the current period compared to a loss in the prior year of $111 thousand. The gain on investment in the current period is from the sale of our $3,250,000 investment in a special purpose vehicle organized by Dream Ventures LLC for $12,838,570.

 

Liquidity and Capital Resources

 

During the nine months ended September 30, 2026, we recorded a net loss from operations of $6,356,253, net income from continued operations of $2,500,306, and a net income of $1,889,443. During that period, we were able to meet our short- and long-term working capital needs and capital expenditure requirements through our available cash and liquid assets.

 

The Company’s capital is generally used to support operations and capital expenditures. However, the Company also, from time-to-time, will review potential investments that it believes present unique situations to participate in growth opportunities. Two such opportunities presented themselves when the Company, during October 2025 and March 2026, invested an aggregate of $3.25 million in a special purpose vehicle (the “SPV”) organized by Dream Ventures LLC, which participated in exempt private placements in an early-stage enterprise developing next-generation nuclear power and infrastructure technologies. The Company’s investment consisted of the acquisition of restricted units of the SPV valued at the time of the investments at $3.25 million. We did not possess a controlling financial interest or exercise significant influence over the SPV, and any proposed transfer of our restricted units requires prior written consent of the SPV.

 

37

 

 

Although the Company is not in the business of making investments in private securities, these investments were viewed by the Board of Directors as a strategic investment intended to access a possible growth opportunity that takes advantage of renewed momentum around modular, rapidly deployable energy systems, supported by recent federal initiatives and Department of Energy programs promoting advanced-reactor innovation. Ultimately, during the nine months ended September 30, 2026, we sold our $3,250,000 investment for $12,838,570 and recognized a $9,588,570 gain.

 

At September 30, 2026, we had working capital of $9.6 million (including $12.9 million in cash and cash equivalents) largely through the sale of our investment in private securities, and a digital asset balance at a fair value of $5,664,813. These amounts were sufficient to sustain our losses from operations during the first nine months of the year. We do not expect that our operating losses will continue at this level for the longer term, since we have implemented initiatives during 2026 to, among others, expand our direct selling network, diversify our revenue base, transition our direct-to-consumer business unit toward a more diversified operating platform, wind-down our bitcoin mining operations starting July 2026, and implement broad-based cost-cutting initiatives. Despite our expectations, our operations have not yet reflected any such expected improvement. We still, however, believe that we will be able to sustain our operations for at least the next twelve months since through September 30, 2026 we were able to monetize our private investments, and at amounts that are significantly appreciated above our purchase price.

 

Should our strategic initiatives fail to mitigate our losses from operations or otherwise fail to achieve their targeted objectives, then in the absence of our ability to access additional debt or equity capital, our ability to sustain our operations in the long-term as a going concern may be subject to doubt.

 

Critical Accounting Policies

 

Basis of Accounting

 

Our policy is to prepare our financial statements on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America.

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations (Regulation S-X) of the Securities and Exchange Commission (the “SEC”) and with the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The results of operations for the nine months ended September 30, 2026, are not necessarily indicative of the operating results that may be expected for our year ending December 31, 2026, as will be included in the filing of our Annual Report on Form 10-K for the year ending December 31, 2026. These unaudited condensed consolidated financial statements should be read in conjunction with the December 31, 2025 consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2025.

 

Use of Estimates

 

The preparation of these financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

Digital Assets

 

Digital assets are included in non-current assets on the Consolidated Balance Sheets due to the Company’s intent to retain and hold bitcoin. Proceeds from the sale of digital assets and the purchase of digital assets are included within investing activities in the accompanying Consolidated Statement of Cash Flows. Digital Assets awarded to the Company through its mining activities and collected for membership revenue are accounted for in connection with the Company’s revenue recognition policy. Following the adoption of Accounting Standards Update (“ASU”) 2023-08 effective January 1, 2025, the Company measures digital assets at fair value with changes recognized in other income (expense) in the Consolidated Statement of Operations. The Company tracks its cost basis of digital assets by-wallet in accordance with the first-in-first-out (“FIFO”) method of accounting. Refer to “NOTE 5 – DIGITAL ASSETS”, in our financial statements for further information regarding the Company’s impact of the adoption of ASU 2023-08.

 

38

 

 

Equity investments without readily determinable fair values

 

Equity investments without readily determinable fair values are accounted for under the measurement alternative. Under the measurement alternative, the carrying value is measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer. Changes in value and impairments of equity investments without readily determinable fair values are recognized in “Gain (loss) on investment” in our condensed consolidated statement of operations. Equity investments without readily determinable fair values are presented as “Equity investment” in our consolidated balance sheet.

 

Intangible Assets

 

We account for our intangible assets in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Subtopic 350-30, General Intangibles Other Than Goodwill, and ASC Subtopic 360-10-05, Accounting for the Impairment or Disposal of Long-Lived Assets (“ASC 350-30”). ASC 350-30 requires assets to be measured based on the fair value of the consideration given or the fair value of the assets (or net assets) acquired, whichever is more clearly evident and, thus, more reliably measurable. Under ASC 350-30 any intangible asset with a useful life is required to be amortized over that life and the useful life is to be evaluated every reporting period to determine whether events or circumstances warrant a revision to the remaining period of amortization. If the estimate of useful life is changed the remaining carrying amount of the intangible asset is amortized prospectively over the revised remaining useful life. Costs of internally developing, maintaining, or restoring intangible assets are recognized as an expense when incurred.

 

Impairment of Long-Lived Assets

 

We have adopted ASC Subtopic 360-10, Property, Plant and Equipment (“ASC 360-10”). ASC 360-10 requires that long-lived assets and certain identifiable intangibles held and used by us be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable or when the historical cost carrying value of an asset may no longer be appropriate. Events relating to recoverability may include significant unfavorable changes in business conditions, recurring losses, or a forecasted inability to achieve break-even operating results over an extended period.

 

We evaluate the recoverability of long-lived assets based upon future net cash flows expected to result from the asset, including eventual disposition. Should impairment in value be indicated, the carrying value of intangible assets will be adjusted and an impairment loss is recorded equal to the difference between the asset’s carrying value and fair value or disposable value. During the nine months ended September 30, 2026, and 2025, no impairment was recorded.

 

Revenue Recognition

 

Membership Revenue

 

Most of our revenue is generated by membership sales and payment is received at the time of purchase. In some cases, customers use earned commissions to pay or partially pay for a membership. We recognize membership revenue in accordance with ASC Subtopic 606-10, Revenue from Contracts with Customers (“ASC 606-10”), where revenue is measured based on a consideration specified in a contract with a customer and recognized when we satisfy the performance obligation specified in each contract. Our performance obligation is to provide our tools, products, and content over a fixed membership period; therefore, we recognize revenue ratably over the membership period and deferred revenue is recorded for the portion of the membership period subsequent to each reporting date. Additionally, we offer a designated trial period to first-time membership customers, during which a full refund can be requested if a customer does not wish to continue with the membership. Revenues are deferred during the trial period as collection is not probable until that time has passed. Revenues are presented net of refunds, sales incentives, credits, and known and estimated credit card chargebacks. As of September 30, 2026, and December 31, 2025, our deferred revenues for membership revenue were $299,254 and $821,903, respectively.

 

39

 

 

Health and Wellness Product Sales and Other Revenue

 

Through our wholly owned subsidiary, Renu Laboratories LLC, we generate revenue by manufacturing and selling health, beauty, and wellness products. We recognize health and wellness product sales revenue in accordance with ASC 606-10. The Company’s performance obligation is complete when control of the promised goods is transferred to a customer, at which time the Company recognizes revenue in an amount that reflects the consideration the Company expects to receive in exchange for those goods. The Company’s terms for the sale are based on free on board (FOB) shipping point, where the control passes to the customer once the product leaves our warehouse. The Company determines collectability by requiring certain customers to pay before control is transferred and by performing ongoing credit evaluations and monitoring customer accounts receivable balances. As of September 30, 2026, and December 31, 2025, deposits collected from customers for orders to be filled at a future date were $76,207 and $108,061, respectively, which are recorded as deferred revenue in the Consolidated Balance Sheets.

 

Shipping and direct costs charged to customers, along with fees collected from customers for storing their products in our warehouse facility located in Warminster, Pennsylvania are included in revenue as Other Revenue. Shipping and direct costs incurred by the Company are included in Cost of Sales and Service.

 

Coffee Sales

 

In January 2026, the Company started selling a proprietary brand of coffee. The Company’s performance obligation is to deliver the coffee to customers. Therefore, revenue is recognized once delivery occurs. Customers remit payment at the time of order placement, therefore payment received by the Company prior to coffee delivery is recorded as deferred revenue. As of September 30, 2026, the Company had $6,352 of deferred revenue for its coffee sales. Shipping and handling costs that occur are paid by the customer and are recorded as revenue. The Company has a policy to provide a refund on any product returned by the customer.

 

Revenue generated for the three months ended September 30, 2026, was as follows:

 

   Membership revenue   Health and wellness product sales   Coffee Sales   Other Revenue   Total 
Gross billings/receipts  $1,933,562   $238,372   $178,678   $3,084   $2,353,696 
Refunds, incentives, credits, and chargebacks   (114,074)   -    (1,042)   -    (115,116)
Net revenue  $1,819,488   $238,372   $177,636   $3,084   $2,238,580 

 

Foreign revenues for the three months ended September 30, 2026 were approximately $0.5 million while domestic revenue for the three months ended September 30, 2026 was approximately $1.7 million.

 

Revenue generated for the three months ended September 30, 2025, was as follows:

 

   Membership revenue   Health and wellness product sales   Other Revenue   Total 
Gross billings/receipts  $7,526,954   $1,041,851   $32,598   $8,601,403 
Refunds, incentives, credits, and chargebacks   (460,220)   (12,178)   -    (472,398)
Net revenue  $7,066,734   $1,029,673   $32,598   $8,129,005 

 

40

 

 

Foreign revenues for the three months ended September 30, 2025, were approximately $6.0 million while domestic revenue for the three months ended September 30, 2025 was approximately $2.1 million.

 

Revenue generated for the nine months ended September 30, 2026, was as follows:

 

   Membership revenue   Health and wellness product sales   Coffee Sales   Other Revenue   Total 
Gross billings/receipts  $6,970,999   $751,409   $661,489   $15,263   $8,399,160 
Refunds, incentives, credits, and chargebacks   (311,116)   (1,713)   (31,348)   -    (344,177)
Net revenue  $6,659,883   $749,696   $630,141   $15,263   $8,054,983 

 

Foreign revenues for the nine months ended September 30, 2026 were approximately $2.8 million while domestic revenue for the nine months ended September 30, 2026 was approximately $5.2 million.

 

Revenue generated for the nine months ended September 30, 2025, was as follows:

 

   Membership revenue   Health and wellness product sales   Other Revenue   Total 
Gross billings/receipts  $25,166,094   $2,722,041   $78,249   $27,966,384 
Refunds, incentives, credits, and chargebacks   (1,463,235)   (12,349)   -    (1,475,584)
Net revenue  $23,702,859   $2,709,692   $78,249   $26,490,800 

 

Foreign revenues for the nine months ended September 30, 2025, were approximately $20.4 million while domestic revenue for the nine months ended September 30, 2025 was approximately $6.0 million.

 

Recent Accounting Pronouncements

 

In December 2023, the FASB issued ASU No. 2023-08, Intangibles—Goodwill and Other—Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets (“ASU 2023-08”). The amendments in ASU 2023-08 are intended to improve the accounting for certain crypto assets by requiring an entity to measure those crypto assets at fair value each reporting period with changes in fair value recognized in net income. The amendments also improve the information provided to investors about an entity’s crypto asset holdings by requiring disclosure about significant holdings, contractual sale restrictions, and changes during the reporting period. The amendments are effective for all entities for fiscal years beginning after December 15, 2024, including interim periods within those fiscal years. The Company adopted ASU 2023-08 for the year ended December 31, 2025, effective as of January 1, 2025, which had a material impact on the financial statements.

 

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 expands existing income tax disclosures for rate reconciliations by requiring disclosure of certain specific categories and additional reconciling items that meet quantitative thresholds and expands disclosures for income taxes paid by requiring disaggregation by certain jurisdictions. ASU 2023-09 is effective for annual periods beginning after December 15, 2024; early adoption is permitted. The Company adopted the ASU for the year ended December 31, 2025. The amendments only impact disclosures and did not have an impact on the Company’s financial condition and results of operations.

 

In November 2024, the FASB issued ASU No. 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40) (“ASU 2024-03”). ASU 2024-03 requires, in the notes to the financial statements, disclosures of specified information about certain costs and expenses specified in the updated guidance. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company did not elect early adoption and is evaluating the impact the updated guidance will have on its disclosures in 2027.

 

41

 

 

We have noted no other recently issued accounting pronouncements that we have not yet adopted that we believe are applicable or would have a material impact on our financial statements.

 

ITEM 3 – QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and, as such, are not required to provide the information under this item.

 

ITEM 4 – CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15 under the Securities Exchange Act of 1934 (the “Exchange Act”) as of the end of the period covered by this Quarterly Report on Form 10-Q. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

 

Our disclosure controls and procedures are designed to provide reasonable, not absolute, assurance that the objectives of our disclosure control system are met. Because of inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, if any, within a company have been detected. Our Chief Executive Officer and Chief Financial Officer have concluded, based on their evaluation as of the end of the period covered by this report, that our disclosure controls and procedures were effective.

 

Changes in Internal Controls

 

There were no changes in our internal controls over financial reporting during the fiscal quarter ended September 30, 2026, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

42

 

 

PART II – OTHER INFORMATION

 

ITEM 1 – LEGAL PROCEEDINGS

 

Except as described in NOTE 10 – COMMITMENTS AND CONTINGENCIES to the condensed consolidated financial statements included in this Report, there have been no material changes to this information since reported on in the Annual Report on Form 10-K for the year ended December 31, 2025.

 

ITEM 1A – RISK FACTORS

 

Except as set forth below, there have been no material changes in the risk factors disclosed by us under Part I, Item 1A. Risk Factors contained in the Annual Report on Form 10-K for the year ended December 31, 2025.

 

Recent Losses from Operations, if unabated, could give rise to a going concern risk.

 

During the nine months ended September 30, 2026, our financial results were adversely affected as we experienced significant headwinds across virtually all of our operating segments. Collectively, the decline in business segment revenue contributed to a consolidated net loss from operations of $6.4 million for the nine months ended September 30, 2026, compared to net loss from operations of $38 thousand for the nine months ended September 30, 2025. Should our losses continue at this level, then, in the absence of our ability to access additional capital, our ability to sustain our operations in the long-term as a going concern will be subject to doubt.

 

We do not expect that our operating losses will continue at this level for the longer term since we have implemented initiatives during 2026 to, among others, expand our direct selling network, diversify our revenue base, transition our direct-to-consumer business unit toward a more diversified operating platform, wind-down our bitcoin mining operations starting July 2026, and implement broad-based cost-cutting initiatives. Our expectations, however, have still not been realized as our operations have not yet reflected any such expected improvement. We believe that we will be able to sustain our operations for at least the next twelve months since through September 30, 2026 we were able to monetize our private investments, and at amounts that are significantly appreciated above our purchase price.

 

ITEM 2 – UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

 

Share repurchase activity during the three months ended September 30, 2026, was as follows:

 

Period  Total Number of Shares Purchased   Average Price Paid per Share   Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs   Maximum Number (or approximate dollar value) of Shares that May Yet Be Purchased under the Plans or Programs(1) 
July 1 – July 31, 2026   327,934   $0.0253    327,934    674,766 
August 1 – August 31, 2026   949,967   $0.0186    949,967    657,070 
September 1 – September 30, 2026   680,940   $0.0142    680,940    647,389 
Total   1,958,841   $0.0182    1,958,841    647,389 

 

(1) On March 6, 2025, the Board of Directors authorized a stock repurchase program that will allow the Company to repurchase up to $1,000,000 in aggregate value of shares of the Company’s common stock, through March 31, 2026. The stock repurchase program was extended to cover the continued repurchase of shares of the Company’s common stock through March 31, 2027.

 

ITEM 3 – DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4 – MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5 – OTHER INFORMATION

 

During the three months ended September 30, 2026, no director or “officer” as defined in Rule 16a-1(f) under the Exchange Act adopted or terminated any Rule 10b5-1 trading arrangements or any non-Rule 10b5-1 trading arrangements, in both cases as defined in Item 408 of Regulation S-K.

 

43

 

 

ITEM 6 – EXHIBITS

 

The following exhibits are filed as a part of this report:

 

Exhibit

Number*

  Title of Document   Location
         
Item 31   Rule 13a-14(a)/15d-14(a) Certifications    
         
31.01   Certification of Principal Executive Officer Pursuant to Rule 13a-14   This filing.
         
31.02   Certification of Principal Financial Officer Pursuant to Rule 13a-14   This filing.
         
Item 32   Section 1350 Certifications    
         
32.01   Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002   This filing.
         
32.02   Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002   This filing.
         
Item 101***   Interactive Data File    
         
101.INS   Inline XBRL Instance Document   This filing.
         
101.SCH   Inline XBRL Taxonomy Extension Schema   This filing.
         
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase   This filing.
         
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase   This filing.
         
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase   This filing.
         
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase   This filing.
         
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)   This filing.

 

 

* All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the sequence of the particular document. Omitted numbers in the sequence refer to documents previously filed as an exhibit.
   
*** Users of this data are advised that, pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or Annual Report for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Exchange Act of 1934 and otherwise are not subject to liability.

 

44

 

 

SIGNATURE PAGE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  INVESTVIEW, INC.
     
Dated: November 13, 2026 By: /s/ Victor M. Oviedo
    Victor M. Oviedo
    Chief Executive Officer
    (Principal Executive Officer)
     
Dated: November 13, 2026 By: /s/ Ralph R. Valvano
    Ralph R. Valvano
    Chief Financial Officer
    (Principal Financial Officer and Accounting Officer)

 

45

 

Keep reading